User interface improvements for medical devices

Abstract
A method and system is disclosed for operating a medical device with or without a cassette in place. A method is disclosed for adding additional VTBI to an ongoing infusion without stopping the infusion and with maintaining the infusion parameters. A method and system is disclosed for changing the CCA without having to interrupt or completely stop an ongoing infusion. Quick titration buttons are provided to allow improved navigation between various delivery display screens.
Description
TECHNICAL FIELD

The present invention relates to medical devices. More specifically, the invention relates to infusion pumps that include touch screen graphical user interfaces.


BACKGROUND OF THE INVENTION

Graphical user interfaces for medical devices that display patient and treatment information have improved clinician efficiency when caring for patients. However, a challenge for designing graphical user interfaces is the need to balance the amount of information displayed on any one screen viewable be the clinician with the need to create a device that is easy to read and navigate. Too often the user is presented with an overwhelming amount of information, impeding the interaction between the user and the user interface.


Additionally, medical devices, including medical pumps, can be complicated and time-consuming for caregivers to program. The need for an improved graphical interface is critical to maintain efficiency of patient care and to reduce potential clinical errors and thereby improve patient safety. Device interfaces that increase input efficiency and accuracy are critical to improve patient safety and therapy.


Graphical user interface design must also take into account strict design parameters as well as safety parameters. As a result, many medical devices do not provide flexibility in programming parameters, neither for the administrator nor for the clinician.


Therefore, it would be desirable to have a medical device that includes a graphical user interface that is easier to navigate, that allows for easier programming of the medical device and that increases efficiency and accuracy of the clinician programming and navigation.


To that end, it is an object of the invention to provide a medical device that is programmable with or without a cassette in place.


It is another object of this invention to provide a medical device wherein a change in clinical care area can be programmed without interruption of an ongoing infusion.


It is another object of this invention to provide a medical device that allows an additional volume to be infused (VTBI) to be programmed before the completion of an ongoing infusion.


It is another object of this invention to provide a medical device with improved navigation buttons.


It is another object of this invention to provide a medical device that allows the clinician to configure the display of infusion data.


It is another object of this invention to provide a medical device with improved alarm features.


It is a further object of the invention to provide a configurable dose-back calculation feature.


SUMMARY OF THE INVENTION

A method and apparatus system is disclosed for operating a medical device with or without a cassette in place. A method is disclosed for adding additional VTBI to an ongoing infusion without stopping the infusion and with maintaining the infusion parameters. A method and system is disclosed for changing the CCA without having to interrupt or completely stop an ongoing infusion. Quick titration buttons are provided to allow improved navigation between various delivery display screens.


The aforementioned and other features and advantages of the invention will become further apparent from the following detailed description of the presently preferred embodiments, read in conjunction with the accompanying drawings. The detailed description and drawings are merely illustrative of the invention rather than limiting, the scope of the invention being defined by the appended claims and equivalents thereof.





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1 is a schematic diagram of the medication management system including a medication management unit and a medical device integrated with an information system, in accordance with the present invention;



FIG. 2 is a schematic diagram of the medication management unit, in accordance with the present invention;



FIG. 3 is a schematic diagram illustrating some of the major functions performed by the medication management unit, in accordance with the present invention;



FIG. 4 is a schematic diagram of a medical device, in accordance with the present invention;



FIG. 5 is perspective view of a multi-channel medical device in communication with a machine-readable input device according to the present invention and shows a split screen display, having one portion associated with each channel, which is adapted to be displayed and viewed from afar during normal delivery of fluid, in accordance with the present invention;



FIG. 5A is a perspective view similar to FIG. 5 and illustrates a near view display screen, in accordance with the present invention;



FIGS. 6A and 6B are screen shots of a graphical user interface for configuring a drug library parameter, in accordance with the present invention;



FIGS. 7A and 7B are screen shots of a graphical user interface for configuring medical device specific parameters, in accordance with the present invention;



FIG. 8 is a flow chart for a program for allowing or disallowing programming of a medical device in regards to the presence of a cassette, in accordance with the present invention;



FIGS. 9A to 9G are screen shots of a graphical user interface, illustrating changing a clinical care area, in accordance with the present invention;



FIG. 10 is a flow chart for a program for changing a clinical care area in a multi-channel infusion pump, in accordance with the present invention;



FIG. 11 is a flow chart for a program for changing a clinical care area in a single channel infusion pump, in accordance with the present invention;



FIGS. 12A to 12F are screen shots of a graphical user interface, illustrating programming of additional VTBI to current infusion, in accordance with the present invention;



FIG. 13 is a flow chart for a program for adding additional VTBI to a current infusion, in accordance with the present invention;



FIG. 14 is a screen shot of a graphical user interface for configuring a display setting at a drug library, in accordance with the present invention;



FIGS. 15A to 15C are screen shots illustrating a graphical user interface for configuring a medical device display parameter, in accordance with the present invention;



FIG. 16 is a flow chart for a program for determining a display parameter, in accordance with the present invention;



FIGS. 17A to 17C are screen shots illustrating a graphical user interface navigation button, in accordance with the present invention;



FIG. 18 is a flow chart for a program for determining a screen view display parameter, in accordance with the present invention;



FIGS. 19A to 19G are screen shots illustrating additional graphical user interface navigation shortcut buttons, in accordance with the present invention;



FIG. 20 is a flow chart for a program for determining a screen view display parameter based on the navigation shortcut buttons, in accordance with the present invention;



FIGS. 21A and 21B are screen shots of various graphical user interface call back alarms, in accordance with the present invention;



FIG. 22 is a flow chart for a program for responding to various call back alarms, in accordance with the present invention;



FIGS. 23A to 23C are screen shots illustrating graphical user interface alarm navigation shortcut buttons, in accordance with the present invention;



FIG. 24 is a flow chart for a program for determining a screen view display parameter based on the alarm navigation shortcut buttons, in accordance with the present invention;



FIG. 25 is a screen shot of a graphical user interface for configuring a dose back calculation parameter at the drug library, in accordance with the present invention;



FIGS. 26A and 26B are screen shots of a graphical user interface for configuring a dose back calculation at the medical device, in accordance with the present invention; and



FIG. 27 is a flow chart for a program for allowing or disallowing a dose back calculation at the medical device, in accordance with the present invention.





DETAILED DESCRIPTION OF THE PRESENTLY PREFERRED EMBODIMENTS

The present invention will be described as it applies to its preferred embodiment. It is not intended that the present invention be limited to the preferred embodiment. It is intended that the invention cover all modifications and alternatives that may be included within the scope of the appended claims


With reference to FIG. 1, the medication management system (MMS) 10 of the present invention includes a medication management unit (MMU) 12 and a medical device 14, typically operating in conjunction with one or more information systems or components of a hospital environment 16. The term hospital environment should be construed broadly herein to mean any medical care facility, including but not limited to a hospital, treatment center, clinic, doctor's office, day surgery center, hospice, nursing home, and any of the above associated with a home care environment. As discussed below, there can be a variety of information systems in a hospital environment. As shown in FIG. 1, the MMU 12 communicates to a hospital information system (HIS) 18 via a caching mechanism 20 that is part of the hospital environment 16.


It will be understood by those of skill in art that the caching mechanism 20 is primarily a pass through device for facilitating communication with the HIS 18 and its functions can be eliminated or incorporated into the MMU 12 (FIG. 1) and/or the medical device 14 and/or the HIS 18 and/or other information systems or components within the hospital environment 16. The caching mechanism 20 provides temporary storage of hospital information data separate from the HIS 18, the medication administration record system (MAR) 22, pharmacy information system (PhIS) 24, physician order entry (POE) 26, and/or Lab System 28. The caching mechanism 20 provides information storage accessible to the Medication Management System 10 to support scenarios where direct access to data within the hospital environment 16 is not available or not desired. For example, the caching mechanism 20 provides continued flow of information in and out of the MMU 12 in instances where the HIS 18 is down or the connectivity between the MMU 12 and the electronic network (not shown) is down.


The HIS 18 communicates with a medication administration record system (MAR) 22 for maintaining medication records and a pharmacy information system (PhIS) 24 for delivering drug orders to the HIS. A physician/provider order entry (POE) device 26 permits a healthcare provider to deliver a medication order prescribed for a patient to the hospital information system directly or indirectly via the PhIS 24. One skilled in the art will also appreciate that a medication order can be sent to the MMU 12 directly from the PhIS 24 or POE device 26. As used herein the term medication order is defined as an order to administer something that has a physiological impact on a person or animal, including but not limited to liquid or gaseous fluids, drugs or medicines, liquid nutritional products and combinations thereof.


Lab system 28 and monitoring device 30 also communicate with the MMU 12 to deliver updated patient-specific information to the MMU 12. As shown, the MMU 12 communicates directly to the lab system 28 and monitoring device 30. However, it will be understood to those of skill in art that the MMU 12 can communicate to the lab system 28 and monitoring device 30 indirectly via the HIS 18, the caching mechanism 20, the medical device 14 or some other intermediary device or system.


Delivery information input device 32 also communicates with the MMU 12 to assist in processing drug orders for delivery through the MMU 12. The delivery information input device 32 can be any sort of data input means, including those adapted to read machine readable indicia such as barcode labels; for example a personal digital assistant (PDA) with a barcode scanner. Hereinafter the delivery information input device 32 will be referred to as input device 32. Alternatively, the machine readable indicia may be in other known forms, such as radio frequency identification (RFID) tag, two-dimensional bar code, ID matrix, transmitted radio ID code, human biometric data such as fingerprints, etc. and the input device 32 adapted to “read” or recognize such indicia. The input device 32 is shown as a separate device from the medical device 14; alternatively, the input device 32 communicates directly with the medical device 14 or may be integrated wholly or in part with the medical device.


With reference to FIG. 2, the medication management unit 12 includes a network interface 34 for connecting the MMU 12 to multiple components of a hospital environment 16, one or more medical devices 14, and any other desired device or network. A processing unit 36 is included in MMU 12 and performs various operations described in greater detail below. A display/input device 38 communicates with the processing unit 36 and allows the user to receive output from processing unit 36 and/or input information into the processing unit 36. Those of ordinary skill in the art will appreciate that display/input device 38 may be provided as a separate display device and a separate input device.


An electronic storage medium 40 communicates with the processing unit 36 and stores programming code and data necessary for the processing unit 36 to perform the functions of the MMU 12. More specifically, the storage medium 40 stores multiple programs formed in accordance with the present invention for various functions of the MMU 12 including but not limited to the following programs: Maintain Drug Library 42; Download Drug Library 44; Process Drug Order 46; Maintain Expert Clinical Rules 48; Apply Expert Clinical Rules 50; Monitor Pumps 52; Monitor Lines 54; Generate Reports 56; View Data 58; Configure the MMS 60; and Monitor the MMS 62. The Maintain Drug Library 42 program creates, updates, and deletes drug entries and establishes a current active drug library. The Download Drug Library 44 program updates medical devices 14 with the current drug library. The Process Drug Order 46 program processes the medication order for a patient, verifying that the point of care (POC) medication and delivery parameters match those ordered. The Maintain Expert Clinical Rules 48 program creates, updates, and deletes the rules that describe the hospital's therapy and protocol regimens. The Apply Expert Clinical Rules 50 program performs logic processing to ensure safety and considers other infusions or medication orders, patient demographics, and current patient conditions. The Monitor Pumps 52 program acquires ongoing updates of status events, and alarms transmitted both real-time and in batch mode, as well as tracking the location, current assignment, and software versions such as the drug library version residing on medical device 14. The Monitor Lines 54 program acquires ongoing updates of status, events and alarms for each channel or line for a medical device 14 that supports multiple drug delivery channels or lines. The Generate Reports 56 program provides a mechanism that allows the user to generate various reports of the data held in the MMU storage medium 40. The View Data 58 program provides a mechanism that supports various display or view capabilities for users of the MMU 12. The Notifications 59 program provides a mechanism for scheduling and delivery of events to external systems and users. The Configure the MMS 60 program provides a mechanism for system administrators to install and configure the MMS 10. The Monitor the MMS 62 program enables information technology operations staff capabilities to see the current status of MMS 10 components and processing, and other aspects of day-to-day operations such as system start up, shut down, backup and restore.


With reference to FIG. 3, the various functional programs 42-62 of the MMU 12, each including separate features and rules, are partitioned (at a higher level than shown in FIG. 2) and logically organized into interrelated managing units of the MMU 12. As shown, the MMU 12 includes an asset manager 64, an alarm manager 66, a drug library manager (such as, for example, is included in HOSPIRA MEDNET software) 68, a caregiver manager 70, a therapy manager 72, and/or a clinical data manager 73. However, one of ordinary skill in the art will appreciate that additional or alternative hospital system managing units can be provided without departing from the present invention. Additionally, the MMU 12 includes a master adjudicator 74 between the separate interrelated hospital system managing units 64-73 of the MMU 12, to regulate the interaction between the separate management units.


Further, while the MMU 12 as described herein appears as a single device, there may be more than one MMU 12 operating harmoniously and sharing the same database. For example the MMU 12 can consist of a collection of MMU specific applications running on distinct servers in order to avoid a single point of failure, address availability requirements, and handle a high volume of requests. In this example, each individual server portion of the MMU 12 operates in conjunction with other server portions of the MMU 12 to redirect service requests to another server portion of the MMU 12. Additionally, the master adjudicator 74 assigns redirected service requests to another server portion of the MMU 12, prioritizing each request and also ensuring that each request is processed.


With reference to FIGS. 2 and 3, the managing units 64-72 each include separate features and rules to govern their operation. For example, the asset manager 64 governs the execution of the Monitor Pumps 52 and Monitor Lines 54 programs; the drug library manager 68 governs the execution of the Drug Library 42 and Download Drug Library 44 programs; the therapy manager 72 governs the execution of the Process Drug Order 46, Maintain Expert Clinical Rules 48, and Apply Expert Clinical Rules 50 programs; and the clinical data manager 73 governs the execution of the Generate Reports 56 and View Data 58 programs. Other distribution of the functional MMU programs 42-62 among the hospital system managing units 64-73 can be made in accordance with the present invention.


With reference to FIG. 4, an electronic network 114 connects the MMU 12, medical device 14, and hospital environment 16 for electronic communication. The electronic network 114 can be a completely wireless network, a completely hard wired network, or some combination thereof.



FIG. 4 is a schematic diagram illustrating several functional components of a medical device 14 for implementing the present invention. Those of ordinary skill in the art will appreciate that the device 14 includes many more components than those shown in FIG. 4. However, it is not necessary that all these components be shown in order to disclose an illustrative embodiment for practicing the present invention.


In the context of the present invention, the term “medical device” includes without limitation a device that acts upon a cassette, reservoir, vial, syringe, or tubing to convey medication or fluid to or from a patient (for example, an enteral pump, a parenteral infusion pump, a patient controlled analgesia (PCA) or pain management medication pump, or a suction pump), a monitor for monitoring patient vital signs or other parameters, or a diagnostic, testing or sampling device.


With reference to FIG. 5, for the purpose of exemplary illustration only, the medical device 14 is disclosed as an infusion pump. More particularly, the medical device 14 can be a single channel infusion pump, a multi-channel infusion pump (as shown), or some combination thereof.


With reference to FIG. 4, the pump style medical device 14 includes a network interface 112 for connecting the medical device 14 to electronic network 114. Where a wireless connection to the electronic network 114 is desired, network interface 112 operates an antenna for wireless connection to the electronic network 114. The antenna can project outside the device 14 or be enclosed within the housing of the device.


A processor 118 is included in the medical device 14 and performs various operations described in greater detail below. The input/output device 120 allows the user to receive output from the medical device 14 and/or input information into the medical device 14. Those of ordinary skill in the art will appreciate that input/output device 120 may be provided as a single device such as a touch screen 122, or as a separate display device and a separate input device (not shown). In the preferred embodiment, the display screen 122 of the medical pump 14 is a thin film transistor active matrix color liquid crystal display with a multi-wire touch screen. A membrane generally impermeable to fluids overlays the display screen 122 so the user can press on images of keys or buttons on the underlying screen with wet gloves, dry gloves or without gloves to trigger an input.


A memory 124 communicates with the processor 118 and stores code and data necessary for the processor 118 to perform the functions of the medical device 14. More specifically, the memory 124 stores multiple programs formed in accordance with the present invention for various functions of the medical device 14 including a graphical user interface program 126 with multiple subparts described in greater detail below.


With reference to FIG. 5, the present invention provides a machine-readable input device 130. The machine-readable input device 130 communicates with the medical device 14 to input machine-readable information to the medical device 14. The machine-readable input device 130 can communicate, directly or indirectly, with the medical device 14 via a wireless or hard-wired connection. The machine-readable input device 130 can be a device that is separate from but associated or in communication with the medical device 14. The machine-readable input device 130 can be any sort of data input means, including those adapted to read machine-readable indicia, such as a barcode scanner or handheld personal digital assistant (PDA). Alternatively, the machine-readable input device 130 may be operable to read in other known forms of machine-readable information, such as radio frequency identification tags (RFID), touch memory, digital photography, biometrics, etc.


With reference to FIG. 5, the medical device 14 is a multi-channel pump having a first channel 132 with first channel machine-readable label 134 and a second channel 136 with a second channel machine-readable label 138. A user of the medical device 14 operates the machine-readable input device 130 to select a channel from one or more channels 132 and 136, by scanning in the associated machine-readable label 134 or 138.


The user selects the desired channel 132 or 136 by using the machine-readable input device 130 to scan a factory or hospital programmed, unique, machine-readable label 134 or 138 that is electronically generated and presented on the screen 122, preferably juxtapositioned near the respective channel 132 or 136. Alternatively, the machine-readable labels 134 and 138 are physically affixed to the medical device 14, preferably on or juxtapositioned near the channel 132 and 136, respectively. Since the machine-readable labels 134 and 138 are generated and/or can be stored in memory 124 by the pump 14, the pump 14 can associate the machine-readable labels 134 and 138 to the channels 132 or 136. The pump 14 then allows the user to program and activate the selected channel 132 or 136. The user may also manually select the desired channel by touching an appropriate folder tab on the touch screen. The folder tabs are labeled and/or physically arranged on the screen so as to be proximate to the corresponding channel 132 or 136.


In a further aspect of the wireless embodiment, all the medical devices can periodically broadcast a unique wireless device/channel IP address and/or a self-generated unique machine-readable label (for example, a barcode) 134 or 138 that can also be presented on the screen 122. Alternatively, the machine-readable labels 134 and 138 are physically affixed to or posted on the medical device 14. Each medical device will correlate such broadcasted or posted device/channel IP addresses and/or barcodes with a particular patient, who is also identified by a unique machine readable label (not shown) or patient IP address. The user associates the desired pump(s) or channel(s) 132, 136 with the patient by using the machine-readable input device 130 to scan the unique machine-readable labels 134, 138 and the patient's machine readable label. This causes the appropriate pump processor(s) 118 to associate the appropriate pump channel(s) 132, 136 with the patient. Then the pumps or channels can associate, communicate, and coordinate with each other wirelessly.


With reference to FIGS. 4, 5, 5A and 17A to 17C, the graphical user interface program 126 reallocates screen 122 for a medical device 14. Specifically, FIGS. 5 and 17B illustrates a multi-channel infusion pump 14 with a split touch screen 122 having a first channel screen portion 140 associated with first channel 132 and a second channel screen portion 142 associated with the second channel 136. Each channel screen portion 140 and 142 presents a subset of the delivery information regarding the respective channels 132 or 136 including without limitation therapeutic agent name, concentration, dose rate, VTBI, and alarm information, in a font size that it is easily readable by a user from a distance such as, for example, from approximately fifteen to twenty feet (4.6-6.2 meters) away. This is what is referred to as a “far view” delivery screen. The far view delivery screens display subsets of the information found on the relevant “near view” delivery screens, illustrated in FIGS. 17A and 17C. The near view delivery screen displays information such as, drug name, concentration, dose rate, time remaining, VTBI, volume remaining, and alarm name for the highest priority alarm if in an alarm state.


In practice, the delivery screen displays a near view when the user is programming the device as illustrated by FIG. 5A. The near view delivery screen will switch to the far view delivery screen after a predetermined period of time that is predetermined by the manufacturer, configurable by the facility via the drug library, and/or set by the caregiver at the pump, for example after 20 seconds. Often, the user does not want to wait for the predetermined length of time to view the far screen. FIGS. 17A to 17C illustrate one embodiment of a medical device that allows the user to switch from the near view screen to the far view screen and vice versa at any time, in accordance with the present invention. FIG. 17A illustrates a near view screen for channel A 1705. If, while in the near view screen, the user wants to view the far view screen, the user touches anywhere within the body 1710 of the near view screen. Touching the body 1710 of the near view screen displays the far view screen 1720 illustrated in FIG. 17B. Referring to FIG. 17B, upon a user touching one of the tabs “A” or “B” or anywhere on the channel screen portions 1725 or 1730 of the far view delivery screen, a “near view” delivery screen is presented on the screen (FIG. 17C). In one embodiment, the user touches a “hotspot” or special toggle button within the body of the current display screen to return to either the far view screen or the near view screen.


Referring to FIG. 18, a flow chart for a program 1800 to immediately transition the display screen between the near view screen and the far view screen is illustrated. Program 1800 begins at block 1801 and progresses to block 1802 where the program determines that the near view delivery screen is displayed. In one aspect of the invention, program 1800 progresses in block 1804 to block 1803 when a near view time out elapses. In another aspect of the invention, program 800 moves from block 1802 to block 1803 when a user touches the near view hotspot in block 1805. Program 1800 may return to the near view screen, block 1802, from the far view screen, block 1803, when a user touches the far view screen in block 1806.


Returning to FIG. 5, the channel screen portion 140 or 142 selected or corresponding to the tab selected expands in area but the size of at least some of the text therein is shrunk, as shown in FIG. 17A. The shrinkage of one of the channel screen portions 140 and 142 and enlargement of its counterpart provides additional space for one or more data display or data entry fields to be placed on screen 122, as shown in FIG. 5A. As discussed below, data displays or data entry fields are placed on screen 122 in space previously occupied by portions of the channel screen portion 140 or 142. This reallocation of space on screen 122 permits the user to enter inputs more easily since the data entry field can be large, preferably at least as large or, more preferably, larger in area than the original channel screen portions 140 and 142 were in the delivery screen mode. Additionally, the reallocation of space on screen 122 provides greater space for presenting information on the channel being adjusted or monitored. Further details on the reallocation of screen 122 and the near view and far view delivery screens can be found in commonly owned and co-pending application U.S. Ser. No. 11/103,235 entitled USER INTERFACE IMPROVEMENTS FOR MEDICAL DEVICES filed on Apr. 11, 2005, which is expressly incorporated herein in its entirety.


Referring again to FIG. 5, pump 14 includes dedicated or fixed tactile infuser buttons, and images of buttons on the LCD-touch screen 122. The fixed tactile buttons 133, 135, 137, and 139 provide the following functions: LOAD/EJECT button 133—opens and closes the cassette carriage; ON/OFF button 135—turns power on and off; ALARM SILENCE button 137—silences a silenceable alarm for a specified period of time, for example two minutes; and EMERGENCY STOP button 139—stops all channels.


The LCD color touch screen 122 allows the user to access and use on-screen button images, for example 3D button images, and data entry fields. The touch screen 122 uses a membrane over the LCD display so a single keypress does not cause significant infusion pole movement nor is it mistaken for a double keypress. The touch screen also accommodates a keypress whether the user is wearing wet gloves, dry gloves, or no gloves.


LCD touch screen button images 143, 145, 147 and 149A-149E are located as shown in FIGS. 5 and 5A and perform the following functions: Patient Information Tab 143—displays the clinical care area, preselected patient information (including without limitation name, ID number, etc.), and provides access to a more detailed patient information screen (FIG. 9C); Channel Level Therapy Buttons 145—accessed by button images on the infuser touch screen, are used to select an infusion therapy; Program Level Buttons 147—accessed by pressing areas, drop-down list triangles, boxes or text boxes on the programming screen, are used to select dose parameters of an infusion; and Device Level Buttons 149A-149E at the bottom of the touch screen are used to display and control device level features, including without limitation Mode 149A (for example, Operational or Biomed), Logs 149B, Locks 149C, Settings 149D, and Calculator display 149E. A wireless indicator image 102 displayed at the bottom of the screen 122 indicates that the device 14 is connected and ready for communication.


By using the Channel Level Therapy Buttons 145 and the Program Level Buttons 147, the healthcare practitioner can program each individual channel of the pump with specific fluid therapies in a variety of weight- and body surface area-based units such as micrograms/kg/hour, grams/m2/hr, and other delivery specifications for the following modes: Basic Therapy—includes dose calculation, which allows dose rate programming based on volume to be infused (VTBI), drug amount, infusion time and drug concentration and simple rate programming that allows programming of volumetric rate (mL/hr) based upon VTBI and time; Bolus delivery—allows user to program a single uninterrupted discrete delivery based on dose amount and time (the bolus can be delivered from the primary or a secondary container); Piggyback delivery—allows user to program the delivery of a secondary infusion, to be delivered through the same cassette as the primary infusion (the primary infusion is paused until the piggyback VTBI completes); and Advanced Programming. Advanced Programming mode provides various types of programs including: Multistep—which allows a sequential delivery of fluid in up to 10 steps, with fluid volumes and delivery rates programmable for each step based on Rate and Volume or Volume and Time; Variable Time—which allows up to 24 dose calculation steps at specified clock times; Intermittent—a calculated dose or step to be delivered at regular intervals; and Taper—a delivery that ramps up and/or ramps down to a plateau rate.


With reference to FIGS. 4 and 5, the graphical user interface 126 provides channel indicators presented on screen 122. The channel indicators associate on-screen programming, delivery, and alarm information with a particular delivery channel by using graphical depictions such as a channel indication icon 154, 155. The channel indication icon 154 or 155 is a graphical item clearly associating on-screen programming, delivery, and alarm information with a specified associated delivery channel. The channel indication icons 154 and 155 are located on a tab 158 associated with a specified delivery channel of the medical device The channel indication icon 154 or 155 may include but is not limited to a user readable letter or number, a machine-readable indicator 134, or a combination thereof. The graphical user interface program 126 also provides a drip indicator icon 160 and an infusion status icon 156 presented on screen 122.


With reference to FIGS. 4, 5, 5A and 19A to 20, in one embodiment of the present invention, the graphical user interface 126 provides quick titration buttons 1910, 1912 presented on a far view screen 122, 1922. FIG. 19A illustrates quick titration buttons for VTBI 1910 and Rate 1912. In another or the same embodiment, graphical user interface 1922 may also have a quick titration button for “dose” or other titration parameters. Quick titration buttons 1910, 1912 operate as explode or active buttons that when pressed take a user to a standard data entry field for data entry when the button is selected. In this manner, with one press of a button the user can be quickly taken to the desired data entry location rather than having to back track through several screens as is common. The quick titration buttons, thus, increase the user's efficiency in programming the medical device in accordance with the present invention. FIGS. 19A to 19G illustrate the use of the VTBI quick titration button 1910. In practice, the user presses quick titration button 1910 (FIG. 19A) to bring up data entry field 1930 in FIG. 19B. In this embodiment, data entry field is a numerical keypad for entering a value for the VTBI. Once the desired value 1935 is entered, the user is prompted to use the keypad to cancel the entry by pressing the cancel button 1940, delete the entry by pressing the clear button 1945, or save the change and continue by pressing the enter button 1950 (FIG. 19C). FIG. 19D illustrates that the user pressed the enter button 1950 to accept and change the VTBI entry. At the graphical user interface illustrated in FIG. 19D, the user has the option to press “Next A” 1955 to continue, “Cancel Titration” 1960 to cancel the titration, or Options 1965 to edit the program. FIG. 19E illustrates that the user pressed “Next A” 1955 to continue. FIG. 19E illustrates a confirmation screen 1970. At this screen, the user is instructed to press “Start Titration A” 1975 to confirm the VTBI change and begin the infusion. At screen 1980 illustrated in FIG. 19F, the user can stop the titration by pressing “Stop Basic A” 1985. The near view screen 1980 illustrated in FIG. 19F returns to a far view screen 1990 shown in FIG. 19G.



FIG. 20 is a flow chart of a program 2000 for operating quick titration buttons for “dose,” “rate” and “VTBI” as discussed above. Program 2000 begins at block 2001 and progresses to block 2005 which indicates that the pump is delivering an infusion and displaying the far view delivery screen (see FIG. 19A). Program 2000 moves to block 2010 when a user presses one of the quick titration buttons 1910, 1912. In response to the pressing of the quick titration button, at block 2015 the program 2000 changes the display to the programming screen for the therapy which is currently delivering (e.g. Channel A or B). After the transition to the near view screen, program 2000 determines at blocks 2020 and 2025 which button was pressed. If the program determines that the Dose button was pressed the program displays the dose numeric keypad, block 2030. If the program determines that the rate button 1912 was pressed, the program displays the rate numeric keypad. If the program determines that neither the dose nor the rate button was pressed, the program displays the VTBI numeric keypad. Those with skill in the art will recognize that program 2000 can determine which button was pressed in any order other than that described herein. Once the keypad for the chosen button is displayed, the user inputs the desired data and continues with the program to confirm and run the infusion with the changed parameter as described above and illustrated in FIGS. 19A to 19G.


With reference to FIGS. 14 to 16, in another aspect of the present invention, the drug library, located within the medication management system and downloaded to the medical device, can be configured to display either the VTBI or the volume infused as a default setting on the far view delivery screen. In another or the same embodiment, the user can change the default setting at the medical device, as provided in more detail below.


With reference to FIG. 14, illustrated is a screen shot of a graphical user interface 1400 for changing a plurality of settings of a drug library for a chosen CCA. In this example, the CCA is the Intensive Care Unit (ICU), though it should be understood that device settings for other CCAs may be similarly configured. The drug library includes drug and device related information, which may include but is not limited to drug name, drug class, drug concentration, drug amount, drug units, diluent amount, diluent units, dosing units, delivery dose or rate, medication parameters or limits, device/infuser settings and/or modes, CCA designations and constraints, and library version. Through the maintain drug library program 42 the drug library may be configured to provide a medical device 14 that includes a customized display. In one embodiment, the display is customized based on the Clinical Care Area (CCA) the medical device 14 is located in, assigned to, and/or to be assigned to.


Once the drug library graphical user interface 1400 for the chosen CCA is displayed, the administrator sets the “default far view setting” 1405 to either VTBI 1410 or volume infused 1415. FIG. 14 shows that VTBI 1410 has been selected as the default far view setting 1405.


With reference to FIGS. 15A to 15C, a user of a medical device having a default far view setting 1405 can change the default setting. To change the default far view setting 1405, the user presses settings button 1525 to access the settings screen 1522. Next, the user presses the far delivery screen button 1530 to access the settings far delivery screen interface 1535 illustrated in FIG. 15B. In this illustration, the default setting was set to display VTBI 1545. To change the default to display “volume infused” the user accesses pull down menu 1550 (FIG. 15C) by activating arrow 1540. Pressing the Volume Infused button 1555 will change the default setting to display the volume infused instead of the VTBI. The user can press the save button (FIG. 15B) or the cancel button 1560 (FIG. 15C) for no change to the default setting.


With reference to FIG. 16, illustrated is a flow chart of a program 1600 for determining at the medical device whether the VTBI should be displayed or the volume infused should be displayed, as described above. Program 1600 begins at block 1601 and proceeds to block 1605 where the display is about to switch from the near view to the far view. Prior to the switch program 1600 determines the display parameter based on the default far view setting 1405 from the drug library for the CCA chosen by the user or the most recent setting established by the user at the device. Based on the current display parameter setting, program 1600 determines at block 1610 whether to display the VTBI. If yes, program 1600 proceeds to 1615 to display VTBI on the far view screen. If no, program 1600 moves to block 1620 to display the volume delivered on the far view screen. Program 1600 ends at 1625. In another embodiment, the near view screen display parameter settings could be similarly configured and/or adjusted.


With reference to FIGS. 5, 6A and 6B, illustrated is graphical user interface 600 of an input device 38 within MMU 12 that is used to configure, within a medication management system all of the associated medical devices 14 as a part of the master infuser setup 610. Pursuant to the present invention, graphical user interface 600 is used by authorized personnel to configure medical device programming parameters. Infusion devices such as the pump 14 require an administration set to perform the infusion. In one embodiment, the administration set is a cassette. The below discussion is in relation to a cassette, however, other types of administration sets as known in the art may be used in accordance with the present invention. Prior art devices require that the cassette be in place prior to programming the pump for an infusion. There are some circumstances within the hospital environment, however, where this requirement is inefficient and wasteful of expensive supplies that go unused, merely because the clinical caregiver has set up an infusion just in case it is need in, for example, the OR, ER or the ICU. In other situations, the time it takes to program a pump only when it is needed may be harmful to the patient, especially in the OR and the emergency room. Conversely, disallowing the programming of a medical device without a cassette may enhance patient safety by, for example, reducing the risk of line confusion during setup.


Therefore, in one aspect of the present invention, the drug library, via the master infuser setup 610, can be configured by a hospital administrator based on hospital policy and procedure. FIGS. 6A and 6B illustrate the configurable parameter 620 of allowing programming of infusion pumps with or without a cassette in place. Thus, at graphical user interface 600, an administrator may choose to allow programming without a cassette by selecting “yes” 630 (FIG. 6B) or disallow programming without a cassette by selecting “no” 640 (FIG. 6A). FIG. 7A illustrates a warning message 720 that appears on screen 700 when a user tries to program the medical device without a required cassette. Once the cassette is loaded, the programming can continue. FIG. 7B illustrates how a programming screen would appear if the programming was started with a cassette in place, whether or not required, or if programming was started without a cassette which has been allowed by the configuration of the master infuser setup 610.


With reference to FIG. 8, a flow chart of a program 800 for determining at the medical device whether the drug library within the memory of the medical device allows the medical device to be programmed with or without a cassette in place. Program 800 begins at 801 and proceeds to 805 where upon some user interaction (e.g. power on), program 800 proceeds to block 810 where the program 800 receives an indication that the user is starting to program a therapy. Upon receiving the indication, program 800 determines at block 815 whether a cassette is required for programming. If no, the program allows the user to proceed, block 820 and the program ends at block 835. However, if at block 815 it is determined that a cassette is required, program 800 determines at block 825 whether a cassette is in place. If yes, program 800 proceeds to block 820 to allow the user to continue and the program ends at 835. If, at block 825, program 800 determines that a cassette is not present, a warning message 720 is displayed that indicates to the user that a cassette is required. The user may either place a cassette as required and continue or discontinue the attempted programming.


Another aspect of the present invention allows the user to modify the CCA without the interruption of a current infusion. FIGS. 9A to 11 illustrate various embodiments of allowing the user to modify the CCA “on the fly.” The ability to change the CCA is this manner increases user and workflow efficiency. In particular, the ability to change the CCA while an infusion is running is crucial where a patient is being transported from one CCA to another such as from the emergency room (ER) to the OR, or from the OR to the ICU. This ability to change the CCA also enhances patient safety where time to wait for an infusion to end may be harmful to the patient. FIGS. 9A to 9G illustrate a series of screen shots of a medical device configured to allow the CCA to be changed while an infusion is ongoing on another channel of the multi-channel pump.



FIG. 9A illustrates that a therapy is delivering on channel A 910 with the ICU CCA 915. In this example, a user wants to change the CCA and program Channel B 920. The user selects channel B by pressing tab B 925, which brings up the channel B programming display screen 930 shown in FIG. 9B. Moving from FIG. 9B to FIG. 9C, the patient information button 940 has been pressed. Pressing the patient information button displays a patient information data field 950 for entry of patient data and changing the CCA 960. When the user presses the CCA button, a “Change CCA” message 965 appears requesting that the user confirm that the CCA is to be changed (FIG. 9D). In this example, the user wants to change the CCA from ICU to Gen Med. To confirm, the user presses the “yes” button 970. In response to the confirmation, a “multiple CCAs” system message 975 appears. To confirm, the user presses the “OK” button 980. Once the OK button 980 has been pressed, the CCA has been changed at 985 and a “Done” button 990 is displayed to continue with the programming of the infusion at infusion screen 995 (FIG. 9G).


With reference to FIG. 10, illustrated is a program 1000 for changing the CCA at a multi-channel medical device 14. Program 1000 starts at 1001 and proceeds to block 1005 where it is determined that the user has changed the CCA. Program 1000 then determines at block 1010 whether the new CCA is the same as the old CCA for Channel A. If yes, the program proceeds to block 1020 to retain the old CCA on Channel A. If no, program 1000 proceeds to block 1015 to determine whether channel A is idle. If yes, program accepts the new CCA on channel A at block 1025. If no, channel A is set to wait at block 1030 until either 1) the user changes the CCA while waiting on channel A (block 1060), whereby program 1000 proceeds to 1005; or 2) channel A becomes idle (block 1065), whereby program 1000 proceeds to block 1025 and accepts the new CCA on channel A.


Additionally, when a user has changed a CCA (block 1005), channel B is evaluated. Program 1000 proceeds from block 1005 to block 1035 to determined whether the new CCA is the same as the old CCA for Channel B. If yes, the program proceeds to block 1045 to retain the old CCA on Channel B. If no, program 1000 proceeds to block 1040 to determine whether channel B is idle. If yes, program 1000 accepts new CCA on channel B, block 1050. If no, channel B is set to wait at block 1055 until either 1) the user changes the CCA while waiting for channel B (block 1070), whereby program 1000 proceeds to 1005; or 2) channel B becomes idle (block 1075), whereby program 1000 proceeds to block 1050 and accepts the new CCA on channel B.


With reference to FIG. 11, illustrated is a program 1100 for changing the CCA at a single channel medical device. Program 1100 starts at 1101 and proceeds to block 1105 where it is determined that the user has changed the CCA. Program 1100 then determined at block 1110 whether the new CCA is the same as the old CCA. If yes, the program proceeds to block 1120 to retain the old CCA. If no, program 1100 proceeds to block 1115 to determine whether the channel is idle. If yes, program 1100 accepts the new CCA, block 1125. If no, the channel is set to wait at block 1130 until either 1) the user changes the CCA while waiting (block 1160), whereby program 1100 proceeds to 1105; or 2) the channel becomes idle (block 1170), whereby program 1100 proceeds to block 1125 and accepts the new CCA.


With reference to FIGS. 12A to 13, illustrated is another aspect of the present invention that allows a medical device 14 user to modify the VTBI parameter to specify additional fluid when an infusion is nearing completion or is delivering in a KVO (keep vein open) mode. A configured medical device that includes a program to allow the additional fluid provides for more efficient workflow as well as a more efficient user. In one embodiment of the invention, the program for allowing additional VTBI maintains all other delivery parameters while allowing the user to specify the additional VTBI. Thus, the user does not have to re-enter common delivery parameters when only an additional VTBI is needed. This reduces programming effort, saves time and reduces the potential for errors.



FIGS. 12A to 12F illustrate, using a series of screen shots, one embodiment of a program for modifying the VTBI delivery parameter. At FIG. 12A, a basic infusion is delivering on channel A, as shown by screen display 1200. At this point in the infusion, FIG. 12A shows that the remaining VTBI is 45.3 mL. FIG. 12B illustrates that the user has pressed “basic” button 1210. A data entry field 1220 appears based on the pressing of the basic button 1210. At data entry field 1220, the user can press the particular field to edit. FIG. 12C illustrates that the user pressed the VTBI button 1230 to edit the VTBI. In response to pressing the VTBI button 1230 a keypad 1240 appears on the display screen. Here, the user enters the total amount of VTBI desired. In this example, the user enters 75 via the keypad 1240 into the data field for VTBI 1245. The user then presses “Enter” 1250 to save the changes and continue. Alternatively, the user can press “Clear” 1255 to delete the entry or cancel 1260 to exit without saving the changes. FIG. 12D illustrates that the VTBI has been changed to 75 mL and entered. FIG. 12D also illustrates that the time remaining has been recalculated and is displayed in area 1270 based on the new VTBI displayed in area 1265. At FIG. 12E, a confirmation of titration screen 1275 has appeared to confirm the new VTBI. The user confirms the change to the VTBI by pressing “Start Titration” button 1280. FIG. 12F illustrates that the infusion has been updated with the new VTBI and is continuing to run. In one embodiment, the method illustrated in FIGS. 12A to 12F is used to add to the VTBI the fluid remaining in the fluid container that is currently infusing. In another embodiment the user may add a new container of fluid as long as all other delivery parameters remain the same as the currently running infusion.



FIG. 13 is a flow diagram illustrating one embodiment of a method 1300 for adding additional VTBI to a current infusion. Method 1300 starts at block 1301 and proceeds to block 1305 where it is determined that the pump is delivering a programmed therapy. Method 1300 continues at block 1310 where the programmed VTBI reached zero and the KVO delivery starts. At block 1315, a user accesses a VTBI programming screen 1220 and enters a VTBI value 1245. The user confirms the new value at block 1320 and starts the new delivery. Method 1300 ends at 1325. One skilled in the art will appreciate from the disclosure herein that such adding of VTBI can also be adapted for use in bolus or piggyback situations.


With reference to FIGS. 21A to 22, one embodiment of the present invention provides for improved callback rules for the medical device. Medical devices generally have three classes of callback alarms based on urgency: High Urgency (e.g. Air-In-Line); Medium Urgency (e.g. Inactivity callback); and Low Urgency (e.g. Battery not Charging). In one embodiment of the invention, the alarms are configured at the drug library. In one embodiment the alarms are configured at the drug library based on the CCA in which the medical device resides. In another embodiment, the alarms are configured at the drug library master infuser settings so that the alarm configurations apply to all medical devices within the medication management system. In other embodiments, the alarms are configurable by the clinician at the medical device. For example, in one embodiment, default alarm settings were configured at the drug library, and sent to the medical device where, depending on the alarm configuration rules set by the hospital administration, a clinician may modify the alarm based on factors such as the particular CCA, or personal preference.


In one embodiment of the invention, a specific alarm type or configuration is assigned to each class of urgency such that a clinician can determine the urgency of the callback alarm upon hearing the alarm. In one embodiment of the invention, each class of alarm is assigned a different melody, a different tone or series of tones and/or a different volume. In other embodiments, the frequency of the alarm is configured based on the class of alarm. In other embodiments, the volume, melody, tone and/or frequency may escalate based on a non-response by the clinician.


In one embodiment of the invention, when an audible alarm occurs at the medical device, the audio volume starts at the volume setting configured at the drug library and or by the clinician. However, if the alarm is not acknowledged, the volume is automatically escalated to a predetermined volume after a predetermined time out period passes. In one embodiment, the time out period is configurable at the drug library. In another embodiment, the time out period is configurable at the drug library for each particular CCA. In yet another embodiment, the time out period is configurable at the medical device. In another embodiment, a default value for the time out period is set at the drug library and may be changed at the medical device to a value that does not exceed the default value. For example, if the default time out period is 20 seconds, the user may set the time out period to less than 20 seconds such as for 10 seconds. In on embodiment of the invention, the volume escalates for only those alarms in the High Urgency class of alarms. In other embodiments, the volume escalates for both High Urgency and Medium Urgency classes of alarms.


In another embodiment of the present invention, the alarm tone escalates after a predetermined time out period if the alarm is not acted upon. In this embodiment, a default tone set at the drug library may be configurable by a user at the medical device. In one embodiment, the pitch of the tone becomes higher when the alarm escalates due to the non-response of the clinician.


In another embodiment of the present invention, the alarm comprises a predetermined tone melody. In one embodiment, a different tone melody is chosen for each class of alarm urgency or priority. In one embodiment, the High Urgency audible alarm is a sequence of six or seven tones that continually repeat until the alarm is acted upon by the clinician. In one embodiment, a brief pause of the tone sequence (melody) occurs between each repeat of the sequence. In one embodiment, the melody for the High Urgency alarm also escalates in volume with continued inactivity by the clinician. In one embodiment, the volume of the melody escalates after a predetermined length of time. In one embodiment, the escalation of volume is configured at the drug library. In another embodiment, the volume escalation is set as a default in the drug library and is further configurable at the medical device by the clinician.


In another or the same embodiment, the Medium Urgency audible alarm is a sequence of three tones. In one embodiment, the tone sequence (melody) repeats after a predetermined length of time if the clinician has not responded to the alarm. In one embodiment the predetermined length of time is 1 to 2 minutes. In another embodiment, the predetermined length of time is from 1 to 60 seconds. In one embodiment, the predetermined length of time is configured at the drug library. In another embodiment, the predetermined length of time is set as a default at the drug library and is further configurable by the clinician at the medical device.


In another embodiment, the Low Urgency audible alarm is a sequence of two tones. In one embodiment, the tone sequence repeats every two to ten minutes until acted upon by the clinician. The time to repeat may be configured as above for the Medium Urgency alarm.


In one embodiment, the High Urgency alarms are configured to have a melody with a very fast paced tempo. While the lesser urgency alarms have a melody with a slower paced tempo. In one embodiment, an alarm comprising a melody escalates in tempo when the alarm is not responded to by the user. In one embodiment, the alarm is configurable by the user at the medical device to a melody of the user's choice. In an example, a melody may be assigned to each user whereby the user sets the alarm on each medical device the user is responsible for to that one melody. In this manner, any one user in a location with multiple users can identify by sound that the alarm is for a medical device of a patient under their specific care.



FIG. 21A illustrates a screen shot of a medical device showing that a channel level callback alarm 2110, 2115 has sounded for each channel A and B where a therapy was partially programmed and no other action was taken by the user. FIG. 21B illustrates a device level callback alarm 2120 has appeared because no keypress was made while a popup 2125 was displaying.


With regard to FIG. 22, a flow chart of a program 2200 for escalating an audible callback alarm, in accordance with the present invention. Program 2200 begins at 2201 and proceeds to block 2205 where an alarm has been activated. At block 2210, program 2200 determines whether the clinician has acknowledged the alarm during a timeout period. If yes, program 2200 proceeds to end at 2235. If no, program 2200 proceeds to block 2215 where a determination is made as to whether the current volume is at a maximum level. If no, program proceeds to block 2220 where the program increases the alarm volume. If yes at block 2215, program 2200 proceeds to block 2225 to determine whether the melody is at a High Urgency and has a melody change been configured. If yes, program 2200 proceeds to end at 2235. If no at block 2225, program 2200 proceeds to block 2230 to change the melody. Program 2200 then proceeds to end at block 2235.


When an alarm occurs on a medical device it may apply to the entire device (e.g. low battery) or it may only apply to a specific channel (e.g. inactivity callback on channel A). If the alarm is channel specific, the user needs to navigate to the channel to view what is causing the callback. In another aspect of the present invention, a device program automatically takes the user to the precise location of the alarm when the user touches the alarm display area on the display screen as will be described below with reference to FIGS. 23A to 23C.



FIGS. 23A to 23C are screen shots of a display interface for a multi-channel infusion pump. In this example, the infusion pump has a therapy programmed for both channel A and channel B. Channel A is idle waiting for the bolus programmed on channel B to complete. FIG. 23A shows that an alarm 2310 has occurred on channel B based on the completion of the bolus infusion programmed on channel B. The drug library or the user had previously configured the pump to stop the infusion or request the pump generate a callback to them when the bolus was complete. When the user presses alarm tab B 2315 the user is taken directly to the display screen 2320 for channel B. Display screen for channel B indicates that the bolus is completed.



FIG. 23A also illustrates that an alarm 2325 has occurred for channel A. When the user presses alarm tab A 2330, the user is taken directly to display screen 2335 shown in FIG. 23C. Display screen 2335 indicates to the user the pump is waiting for input from the user. The user must clear the alarm and provide the necessary input before the infusion scheduled on channel A may be started by pressing Start 2340. The ability for a user to navigate quickly to the cause of the alarm improves efficiency of the user as well as workflow. Additionally, the ability to navigate directly to the cause of the alarm decreases or eliminates errors that may occur if the user had to take many steps to navigate to the appropriate display screen.


With reference to FIG. 24, a flow chart for one embodiment for a program 2400 for navigating directly to a cause of an alarm is shown in accordance with the present invention. Program 2400 begins at block 2401 and proceeds to block 2405 where an alarm has been activated. In response to the alarm, an acknowledgement is received from the user in response to the user pressing an alarm tab in block 2410. Program 2400 determines at block 2415 whether the alarm was for channel A. If yes, the program proceeds to block 2420 where the program navigates to the screen on channel A from where the alarm is arising if the current screen is allowed to be navigated away from. At block 2425, the user takes appropriate action in relation to the alarm. If, at block 2415, the program determines that the alarm is not for channel A, program 2400 proceeds to block 2430 where it is determined whether the alarm is for channel B. If yes, the program proceeds to block 2435 where the program navigates to the screen on channel B from where the alarm is arising if the current screen is allowed to be navigated away from. If at block 2430, the alarm is not for channel B, program 2400 proceeds to block 2440. At block 2440, the program determines that no navigation is required and proceeds to block 2425 where the user is instructed to take a specific action. Program 2400 ends at 2445.


In another embodiment of the present invention, the drug library may be configured to allow for a dose back calculation during the programming of an infusion delivery. During the programming of an infuser for a dose-based therapy (e.g. weight or BSA based therapy), the user must enter the dose first before being allowed to enter the rate. In certain clinical scenarios it is preferable for the user to enter the rate first and the dose is calculated from the rate. Providing this flexibility to the user and the hospital administration allows for increased efficiency and better work flow.



FIG. 25 illustrates a graphical user interface 2500 for configuring a drug library. A default “dose back calculate” can be set at 2510. To enable the dose back calculation at the medical device, an administrator selects “enabled” 2520. To disable the dose back calculation at the medical device, the administrator selects “disabled” 2530.



FIG. 26A is a screen shots of a medical device that allows for the dose back calculation as determined within the drug library. The user is allowed to enter dose, rate, etc. in any order as further described below. FIG. 26B is a screen shot of a medical device that disallows for the dose back calculation as determined within the drug library. The user is forced by the user interface to enter the dose first.


With reference to FIG. 27, illustrated is a flow chart of a program 2700 residing in the medical device for programming a drug and calculating a dose. Program 2700 begins at 2701 and proceeds to block 2705 where the program determines if the user selected a dose-based drug. If not, program 2700 proceeds to block 2710 where program 2700 determines whether the dose back calculation is enabled at the drug library. If yes, program 2700 proceeds to block 2715, where program 2700 enables dose, rate, VTBI, time and/or weight/BSA fields. Program 2700 proceeds to 2720 where it is determined whether the user entered the dose or the rate. If dose, program 2700 proceeds to block 2725 to calculate rate based on the provided dose. If rate, program 2700 proceeds to block 2735 to calculate the dose based on the provided rate.


If at block 2710 the dose-back calculation is not enabled, program 2700 proceeds to block 2740 where program 2700 enables a dose field as well as weight/BSA if required. Program 2700 proceeds to block 2745 where a dose is provided as well as weight/BSA if required. Next, a rate is calculated based on the entered dose. Program 2700 proceeds to block 2755 where rate, VTBI and time fields are enabled. Program 2700 ends at 2730.


One skilled in the art will appreciate from this disclosure that the functionality shown in the figures and described herein is made possible by computer program code, and as such those features could be combined, distributed or shared among the processors of the pump 14, the MMU 12, or other computers within the healthcare facility without detracting from the present invention. Those skilled in the art will also recognize from this disclosure that selecting the CCA and providing other information or input can be done via scanning or passively receiving input from drug containers, a patient identifier, a nurse identifier or other similar items.


While the embodiments of the invention disclosed herein are presently considered to be preferred, various changes and modifications can be made without departing from the scope of the invention. The scope of the invention is indicated in the appended claims, and all changes and modifications that come within the meaning and range of equivalents are intended to be embraced therein.

Claims
  • 1. A medical device operably connected to a medication management unit, the device comprising: a display screen configured to display a first user interface,the first user interface comprising: a first display portion separately displaying a plurality of channel summary portions respectively corresponding to each channel of an infusion pump including a first channel summary portion and a second channel summary portion, the first channel summary portion displaying first infusion parameters corresponding to a first fluid pump channel of the infusion pump andthe second channel summary portion displaying second infusion parameters corresponding to a second fluid pump channel of the infusion pump;a second display portion separately displaying a plurality of channel programming portions respectively corresponding to each of the channels of the infusion pump including a first channel programming portion including selectable screens for different first channel programming options anda second channel programming portion including selectable screens for different second channel programming options,wherein the first channel programming portion displaying programmable first infusion parameters corresponding to the first fluid pump channel of the infusion pump and the second channel programming portion displaying programmable second infusion parameters corresponding to the second fluid pump channel of the infusion pump, anda third display portion separately displaying a plurality of channel alarm tabs corresponding to each of the channels of the infusion pump including a first channel alarm tab corresponding to the first fluid pump channel and a second channel alarm tab corresponding to the second fluid pump channel, each of the channel alarm tabs including a tab label portion and a tab content portion including an alarm description, and a direct alarm navigation link corresponding to a selected one of the plurality of channel alarm tabs, wherein the third display portion displays each of the tab label portions and only the tab content portion of the selected one of the plurality of channel alarm tabs;wherein the first display portion, the second display portion, and the third display portion are simultaneously displayed on the first user interface andwherein selection of the direct alarm navigation link of the selected one of the plurality of channel alarm tabs directly navigates the display screen to display a second user interface simultaneously displaying the first display portion, the second display portion, and the third display portion with the second display portion only displaying infusion parameters corresponding to the selected alarm navigation link of the selected one of the plurality of channel alarm tabs.
  • 2. The medical device of claim 1, wherein the second user interface further includes a clear alarm portion that returns the display screen back to the first user interface based on user interaction with the clear alarm portion.
  • 3. The medical device of claim 1, wherein the display screen remains on the first user interface for device level alarms.
  • 4. The medical device of claim 1, wherein the alarm description further includes text corresponding to status of the respective fluid pump channel.
  • 5. A medical device method for managing a display screen of a medication management unit, the medical device method comprising: displaying, on a first user interface, a first display portion that separately displays a plurality of channel summary portions respectively corresponding to each channel of an infusion pump including a first channel summary portion and a second channel summary portion, the first channel summary portion displaying first infusion parameters corresponding to a first fluid pump channel of the infusion pump, andthe second channel summary portion displaying second infusion parameters corresponding to a second fluid pump channel of the infusion pump;displaying, on the first user interface, a second display portion that separately displays a plurality of channel programming portions respectively corresponding to each of the channels of the infusion pump including: a first channel programming portion including selectable screens for different first channel programming options, anda second channel programming portion including selectable screens for different second channel programming options,wherein the first channel programming portion separately displaying programmable first infusion parameters corresponding to the first fluid pump channel of the infusion pump and the second channel programming portion displaying programmable second infusion parameters corresponding to the second fluid pump channel of the infusion pump; anddisplaying, on the first user interface, a third display portion including a plurality of channel alarm tabs corresponding to each of the channels of the infusion pump including a first channel alarm tab corresponding to the first fluid pump channel and a second channel alarm tab corresponding to the second fluid pump channel, each of the channel alarm tabs including a tab label portion and a tab content portion including an alarm description, and a direct alarm navigation link corresponding to a selected one of the plurality of channel alarm tabs,wherein the third display portion separately displays each of the tab label portions and only the tab content portion of the selected one of the plurality of channel alarm tabs; andwherein the first display portion, the second display portion, and the third display portion are simultaneously displayed on the first user interface, andwherein selection of the direct alarm navigation link of the selected one of the plurality of channel alarm tabs directly navigates the display screen to a second user interface, said second user interface simultaneously displaying the first display portion, the second display portion, and the third display portion with the second display portion displaying only infusion parameters corresponding to the selected alarm navigation link of the selected one of the plurality of channel alarm tabs.
CROSS REFERENCE TO RELATED APPLICATIONS

This application claims priority based upon U.S. Provisional Application Ser. No. 61/014,677 filed Dec. 18, 2007, which is expressly incorporated herein by reference in its entirety.

US Referenced Citations (1516)
Number Name Date Kind
554115 Fisher Feb 1896 A
3401337 Beusman et al. Sep 1968 A
3484681 Grady, Jr. et al. Dec 1969 A
3699320 Zimmerman et al. Oct 1972 A
3727074 Keller et al. Apr 1973 A
3731679 Wilhelmson et al. May 1973 A
3768084 Haynes Oct 1973 A
3770354 Tsuruta et al. Nov 1973 A
3778702 Finger Dec 1973 A
3806821 Niemeyer et al. Apr 1974 A
3838565 Carlyle Oct 1974 A
3854038 McKinley Dec 1974 A
3886459 Hufford et al. May 1975 A
3890554 Yoshitake et al. Jun 1975 A
3898637 Wolstenholme Aug 1975 A
3901231 Olson Aug 1975 A
3909693 Yoshitake et al. Sep 1975 A
3910701 Henderson Oct 1975 A
3911343 Oster Oct 1975 A
3919608 Usami et al. Nov 1975 A
3921622 Cole Nov 1975 A
3930404 Ryden, Jr. Jan 1976 A
3933431 Trujillo et al. Jan 1976 A
3935876 Massie et al. Feb 1976 A
3944963 Hively Mar 1976 A
3966358 Heimes et al. Jun 1976 A
3971980 Jungfer et al. Jul 1976 A
3974681 Namery Aug 1976 A
3974683 Martin Aug 1976 A
3985467 Lefferson Oct 1976 A
3990444 Vial Nov 1976 A
3997888 Kremer Dec 1976 A
4005724 Courtot Feb 1977 A
4014206 Taylor Mar 1977 A
4038982 Burke Aug 1977 A
4039269 Pickering Aug 1977 A
4048474 Olesen Sep 1977 A
4049954 Da Costa Vieira et al. Sep 1977 A
4055175 Clemens et al. Oct 1977 A
4068521 Cosentino et al. Jan 1978 A
4078562 Friedman Mar 1978 A
4089227 Falgari et al. May 1978 A
4094318 Burke Jun 1978 A
4105028 Sadlier et al. Aug 1978 A
4114144 Hyman Sep 1978 A
4151845 Clemens May 1979 A
4155362 Jess May 1979 A
4173224 Marx Nov 1979 A
4181610 Shintani et al. Jan 1980 A
4183244 Kohno et al. Jan 1980 A
4195515 Smoll Apr 1980 A
4210138 Jess et al. Jul 1980 A
4213454 Shim Jul 1980 A
4217993 Jess et al. Aug 1980 A
4240294 Grande Dec 1980 A
4240438 Updike et al. Dec 1980 A
4244365 McGill Jan 1981 A
4256437 Brown Mar 1981 A
4261356 Turner et al. Apr 1981 A
4264861 Radu et al. Apr 1981 A
4265240 Jenkins May 1981 A
4270532 Franetzki et al. Jun 1981 A
4277226 Archibald et al. Jul 1981 A
4278085 Shim Jul 1981 A
4280495 Lampert Jul 1981 A
4282872 Franetzki et al. Aug 1981 A
4286202 Clancy et al. Aug 1981 A
4290346 Bujan Sep 1981 A
4291692 Bowman et al. Sep 1981 A
4292405 Mascoli Sep 1981 A
4298357 Permic Nov 1981 A
4308866 Jeliffe Jan 1982 A
4312341 Zissimopoulos Jan 1982 A
4319568 Tregoning Mar 1982 A
4322201 Archibald Mar 1982 A
4323849 Smith Apr 1982 A
4324662 Schnell Apr 1982 A
4328800 Marx May 1982 A
4328801 Marx May 1982 A
4333045 Oltendorf Jun 1982 A
4343316 Jespersen Aug 1982 A
4344429 Gupton et al. Aug 1982 A
4346707 Whitney et al. Aug 1982 A
4360019 Portner et al. Nov 1982 A
4366384 Jensen Dec 1982 A
4367736 Gupton Jan 1983 A
4370983 Lichtenstein et al. Feb 1983 A
4373527 Fischell Feb 1983 A
4379452 Devries Apr 1983 A
4381005 Bujan Apr 1983 A
4384578 Winkler May 1983 A
4385247 Satomi May 1983 A
4391598 Thompson Jul 1983 A
4392849 Petre et al. Jul 1983 A
4394862 Shim Jul 1983 A
4395259 Prestele et al. Jul 1983 A
4397194 Soltz Aug 1983 A
4399362 Cormier et al. Aug 1983 A
4407659 Adam Oct 1983 A
4411651 Schulman Oct 1983 A
4418565 St. John Dec 1983 A
4432699 Beckman et al. Feb 1984 A
4432761 Dawe Feb 1984 A
4432762 Dawe Feb 1984 A
4443218 Decant, Jr. et al. Apr 1984 A
4444546 Pazemenas Apr 1984 A
4447191 Bilstad et al. May 1984 A
4447224 Decant, Jr. et al. May 1984 A
4453931 Pastrone Jun 1984 A
4457751 Rodler Jul 1984 A
4463301 Moriguchi et al. Jul 1984 A
4464170 Clemens Aug 1984 A
4467654 Murakami et al. Aug 1984 A
4468222 Lundquist Aug 1984 A
4468601 Chamran et al. Aug 1984 A
4469481 Kobayashi Sep 1984 A
4475666 Bilbrey et al. Oct 1984 A
4475901 Kraegen et al. Oct 1984 A
4477756 Moriguchi Oct 1984 A
4479760 Bilstad et al. Oct 1984 A
4480218 Hair Oct 1984 A
4480483 McShane Nov 1984 A
4483202 Ogua et al. Nov 1984 A
4487601 Lindemann Dec 1984 A
4492909 Hartwig Jan 1985 A
4496346 Mosteller Jan 1985 A
4498843 Schneider et al. Feb 1985 A
4501531 Bilstad et al. Feb 1985 A
4504263 Steuer Mar 1985 A
4507112 Hillel Mar 1985 A
4510266 Eertink Apr 1985 A
4515584 Abe et al. May 1985 A
4519792 Dawe May 1985 A
4521212 Ruschke Jun 1985 A
4525163 Slavik et al. Jun 1985 A
4526568 Clemens et al. Jul 1985 A
4526574 Pekkarinen Jul 1985 A
4529401 Leslie et al. Jul 1985 A
4533350 Danby et al. Aug 1985 A
4543955 Schroeppel Oct 1985 A
4551134 Slavik et al. Nov 1985 A
4553958 LeCocq Nov 1985 A
4559036 Wunsch Dec 1985 A
4559037 Franetzki et al. Dec 1985 A
4559044 Robinson Dec 1985 A
4559454 Kramer Dec 1985 A
4565500 Jeensalaute et al. Jan 1986 A
4583981 Urquhart et al. Apr 1986 A
4587473 Turvey May 1986 A
4607520 Dam Aug 1986 A
4617014 Cannon et al. Oct 1986 A
4624661 Arimond Nov 1986 A
4627835 Fenton, Jr. Dec 1986 A
4633878 Bombardieri Jan 1987 A
4634426 Kamen Jan 1987 A
4634427 Hannula et al. Jan 1987 A
4636144 Abe et al. Jan 1987 A
4637813 Devries Jan 1987 A
4645489 Krumme Feb 1987 A
4648869 Bobo, Jr. Mar 1987 A
4652260 Fenton, Jr. et al. Mar 1987 A
4658244 Meijer Apr 1987 A
4668216 Martin May 1987 A
4668945 Aldrovandi et al. May 1987 A
4673334 Allington et al. Jun 1987 A
4673389 Archibald et al. Jun 1987 A
4676776 Howson et al. Jun 1987 A
4677359 Enami et al. Jun 1987 A
4678979 Hori Jul 1987 A
4678998 Muramatsu Jul 1987 A
4679562 Luksha Jul 1987 A
4683428 Gete Jul 1987 A
4685903 Cable et al. Aug 1987 A
4690673 Bloomquist Sep 1987 A
4691153 Nishimura Sep 1987 A
4692145 Weyant Sep 1987 A
4696671 Epstein et al. Sep 1987 A
4697129 Enami et al. Sep 1987 A
4702675 Aldrovandi et al. Oct 1987 A
4705506 Archibald et al. Nov 1987 A
4710106 Iwata et al. Dec 1987 A
4714462 DiDomenico Dec 1987 A
4714463 Archibald et al. Dec 1987 A
4718576 Tamura et al. Jan 1988 A
4720636 Benner Jan 1988 A
4722224 Scheller et al. Feb 1988 A
4722734 Kolin Feb 1988 A
4731051 Fischell Mar 1988 A
4731057 Tanaka et al. Mar 1988 A
4737711 O'Hare Apr 1988 A
4739346 Buckley Apr 1988 A
4741732 Crankshaw et al. May 1988 A
4741736 Brown May 1988 A
4748857 Nakagawa Jun 1988 A
4751445 Sakai Jun 1988 A
4756706 Kerns Jul 1988 A
4758228 Williams Jul 1988 A
4763525 Cobb Aug 1988 A
4764166 Spani et al. Aug 1988 A
4764697 Christiaens Aug 1988 A
4776842 Franetzki et al. Oct 1988 A
4781687 Wall Nov 1988 A
4784576 Bloom et al. Nov 1988 A
4785184 Bien et al. Nov 1988 A
4785799 Schoon et al. Nov 1988 A
4785969 McLaughlin Nov 1988 A
4786800 Kamen Nov 1988 A
4789014 DiGianfilippo Dec 1988 A
4797655 Orndal et al. Jan 1989 A
4803389 Ogawa et al. Feb 1989 A
4803625 Fu et al. Feb 1989 A
4818186 Pastrone et al. Apr 1989 A
4820281 Lawler Apr 1989 A
4821558 Pastrone et al. Apr 1989 A
4828545 Epstein et al. May 1989 A
4828693 Lindsay May 1989 A
4829448 Balding et al. May 1989 A
4838856 Mulreany et al. Jun 1989 A
4838857 Strowe et al. Jun 1989 A
4840542 Abbott Jun 1989 A
4842584 Pastrone et al. Jun 1989 A
4845487 Frantz et al. Jul 1989 A
4846792 Bobo et al. Jul 1989 A
4850805 Madsen et al. Jul 1989 A
4851755 Fincher Jul 1989 A
4854324 Hirschman et al. Aug 1989 A
4856339 Williams Aug 1989 A
4857048 Simons et al. Aug 1989 A
4857050 Lentz et al. Aug 1989 A
4858154 Anderson et al. Aug 1989 A
4863425 Slate et al. Sep 1989 A
4865584 Epstein et al. Sep 1989 A
4869722 Heyman Sep 1989 A
4874359 White et al. Oct 1989 A
4881413 Georgi et al. Nov 1989 A
4882575 Kawahara Nov 1989 A
4884013 Jackson et al. Nov 1989 A
4884065 Crouse et al. Nov 1989 A
4886422 Takeuchi et al. Dec 1989 A
4898576 Philip Feb 1990 A
4898578 Rubalcaba Feb 1990 A
4906103 Kao Mar 1990 A
4908017 Howson et al. Mar 1990 A
4910475 Lin Mar 1990 A
4919595 Likuski et al. Apr 1990 A
4919596 Slate et al. Apr 1990 A
4925444 Orkin et al. May 1990 A
4927411 Laenen et al. May 1990 A
4930358 Motegi et al. Jun 1990 A
4936820 Dennehey Jun 1990 A
4936828 Chiang Jun 1990 A
4938079 Goldberg Jul 1990 A
4943279 Samiotes et al. Jul 1990 A
4946439 Eggers Aug 1990 A
4947856 Beard Aug 1990 A
4950235 Slate et al. Aug 1990 A
4950244 Fellingham Aug 1990 A
4959050 Bobo, Jr. Sep 1990 A
4966579 Polaschegg Oct 1990 A
4968941 Rogers Nov 1990 A
4972842 Korten et al. Nov 1990 A
4976687 Martin Dec 1990 A
4978335 Arthur, III Dec 1990 A
4979940 Lapp et al. Dec 1990 A
4981467 Bobo et al. Jan 1991 A
5000663 Gorton Mar 1991 A
5000739 Kulisz et al. Mar 1991 A
5006050 Cooke et al. Apr 1991 A
5010473 Jacobs Apr 1991 A
5014714 Millay et al. May 1991 A
5018945 D'Silva May 1991 A
5026348 Venegas Jun 1991 A
5028857 Taghezout Jul 1991 A
5032112 Fairchild et al. Jul 1991 A
5034004 Crankshaw Jul 1991 A
5035143 Latimer et al. Jul 1991 A
5041086 Koenig et al. Aug 1991 A
5043706 Oliver Aug 1991 A
5045069 Imparato Sep 1991 A
5049047 Polaschegg et al. Sep 1991 A
5052230 Lang Oct 1991 A
5053747 Slate Oct 1991 A
5055761 Mills Oct 1991 A
5056992 Simons Oct 1991 A
5058161 Weiss Oct 1991 A
5059171 Bridge Oct 1991 A
5063603 Burt Nov 1991 A
5064412 Henke Nov 1991 A
5078683 Sancoff et al. Jan 1992 A
5084663 Olsson Jan 1992 A
5084828 Kaufman et al. Jan 1992 A
5088981 Howson et al. Feb 1992 A
5096385 Georgi et al. Mar 1992 A
5097505 Weiss Mar 1992 A
5100380 Epstein et al. Mar 1992 A
5102392 Sakai et al. Apr 1992 A
5103211 Daoud et al. Apr 1992 A
5104374 Bishko et al. Apr 1992 A
5108367 Epstein et al. Apr 1992 A
5109850 Blanco et al. May 1992 A
5116203 Nartwick et al. May 1992 A
5116312 Blakenship et al. May 1992 A
5116316 Sertic May 1992 A
5123275 Daoud et al. Jun 1992 A
5124627 Okada Jun 1992 A
5125499 Saathoff et al. Jun 1992 A
5131816 Brown Jul 1992 A
5132603 Yoshimoto Jul 1992 A
5153827 Coutre et al. Oct 1992 A
5158441 Aid Oct 1992 A
5161222 Montejo et al. Nov 1992 A
5174472 Raque et al. Dec 1992 A
5176631 Koenig Jan 1993 A
5176646 Kuroda Jan 1993 A
5179340 Rogers Jan 1993 A
5180287 Natwick et al. Jan 1993 A
5181910 Scanlon Jan 1993 A
5186057 Everhart Feb 1993 A
5188603 Vaillancourt Feb 1993 A
5190522 Wocicki et al. Mar 1993 A
5191795 Fellingham et al. Mar 1993 A
5192340 Grant et al. Mar 1993 A
5194796 Domeki et al. Mar 1993 A
5198776 Carr Mar 1993 A
5200090 Ford Apr 1993 A
5205819 Ross et al. Apr 1993 A
5206522 Danby et al. Apr 1993 A
5207642 Orkin et al. May 1993 A
5211626 Frank et al. May 1993 A
5213573 Sorich et al. May 1993 A
5215450 Tamari Jun 1993 A
5216597 Beckers Jun 1993 A
5219099 Spence et al. Jun 1993 A
5219327 Okada Jun 1993 A
5221268 Barton et al. Jun 1993 A
5229713 Bullock et al. Jul 1993 A
5232476 Grant Aug 1993 A
5233571 Wirtschafter Aug 1993 A
5237309 Frantz et al. Aug 1993 A
5242406 Gross et al. Sep 1993 A
5242408 Jhuboo et al. Sep 1993 A
5243982 Möstl et al. Sep 1993 A
5244463 Cordner, Jr. et al. Sep 1993 A
5244568 Lindsay et al. Sep 1993 A
5254096 Rondelet et al. Oct 1993 A
5256155 Yerlikaya et al. Oct 1993 A
5256156 Kern et al. Oct 1993 A
5256157 Samiotes et al. Oct 1993 A
5260665 Goldberg Nov 1993 A
5257206 Hanson Dec 1993 A
5267980 Dirr et al. Dec 1993 A
5274316 Evans et al. Dec 1993 A
5276610 Maeda et al. Jan 1994 A
5280728 Sato et al. Jan 1994 A
5283510 Tamaki et al. Feb 1994 A
5287851 Beran et al. Feb 1994 A
5292306 Wynkoop et al. Mar 1994 A
5295967 Rondelet et al. Mar 1994 A
5298021 Sherer Mar 1994 A
5303585 Lichte Apr 1994 A
5304126 Epstein et al. Apr 1994 A
5304216 Wallace Apr 1994 A
5308333 Skakoon May 1994 A
5317506 Coutre et al. May 1994 A
5319363 Welch et al. Jun 1994 A
5319979 Abrahamson Jun 1994 A
5321392 Skakoon et al. Jun 1994 A
5325170 Bornhop Jun 1994 A
5325728 Zimmerman et al. Jul 1994 A
5328460 Lord et al. Jul 1994 A
5330634 Wong et al. Jul 1994 A
5333497 Braend et al. Aug 1994 A
5336051 Tamari Aug 1994 A
5338157 Blomquist Aug 1994 A
5342298 Michaels Aug 1994 A
5343734 Maeda et al. Sep 1994 A
5343885 Grant Sep 1994 A
5346466 Yerlikaya et al. Sep 1994 A
5356378 Doan et al. Oct 1994 A
5359271 Husher Oct 1994 A
D352778 Irvin et al. Nov 1994 S
5364346 Schrezenmeir Nov 1994 A
5366346 Danby Nov 1994 A
5368562 Blomquist Nov 1994 A
5374865 Yoshimura et al. Dec 1994 A
5376070 Purvis et al. Dec 1994 A
5378231 Johnson et al. Jan 1995 A
5382232 Hague et al. Jan 1995 A
5383369 Khuri-Yakub et al. Jan 1995 A
5389071 Kawahara et al. Feb 1995 A
5389078 Zalesky et al. Feb 1995 A
5392638 Kawahara Feb 1995 A
5394732 Johnson et al. Mar 1995 A
5395320 Padda et al. Mar 1995 A
5399171 Bowman et al. Mar 1995 A
5406954 Tomita Apr 1995 A
5408326 Priestley Apr 1995 A
5415528 Ogden et al. May 1995 A
5417119 Smoll May 1995 A
5417222 Dempsey et al. May 1995 A
5417395 Fowler et al. May 1995 A
5418443 Kikuchi May 1995 A
5421208 Packard et al. Jun 1995 A
5423748 Uhala Jun 1995 A
5423759 Campbell Jun 1995 A
5428284 Kaneda et al. Jun 1995 A
5429485 Dodge Jul 1995 A
5429601 Conley Jul 1995 A
5429602 Hauser Jul 1995 A
5431627 Pastrone et al. Jul 1995 A
5434508 Ishida Jul 1995 A
5437624 Langley et al. Aug 1995 A
5444316 Ohya et al. Aug 1995 A
5444378 Rogers Aug 1995 A
5445621 Poli et al. Aug 1995 A
5450758 Smoll Sep 1995 A
5451881 Finger Sep 1995 A
5455423 Mount et al. Oct 1995 A
5455851 Chaco et al. Oct 1995 A
5463906 Spani et al. Nov 1995 A
5464392 Epstein et al. Nov 1995 A
5465082 Chaco Nov 1995 A
5469851 Lipschutz Nov 1995 A
5473948 Moss et al. Dec 1995 A
5480294 Di Perna et al. Jan 1996 A
5482438 Anderson et al. Jan 1996 A
5485408 Blomquist Jan 1996 A
5486286 Peterson et al. Jan 1996 A
5489265 Montalvo et al. Feb 1996 A
5495566 Kwatinetz Feb 1996 A
5496273 Pastrone et al. Mar 1996 A
5505696 Miki Apr 1996 A
5505828 Wong et al. Apr 1996 A
5507288 Bocker et al. Apr 1996 A
5507412 Ebert et al. Apr 1996 A
5520637 Pager et al. May 1996 A
5522798 Johnson et al. Jun 1996 A
5522799 Furukawa Jun 1996 A
5527630 Nagata Jun 1996 A
5533389 Kamen et al. Jul 1996 A
5537853 Finburgh et al. Jul 1996 A
5542040 Chang et al. Jul 1996 A
5545140 Conero et al. Aug 1996 A
5547470 Johnson et al. Aug 1996 A
5551850 Williamson et al. Sep 1996 A
5554013 Owens et al. Sep 1996 A
5554115 Thomas et al. Sep 1996 A
5558638 Evers et al. Sep 1996 A
5562615 Nassif Oct 1996 A
5563486 Yamamoto et al. Oct 1996 A
5572105 Nojima et al. Nov 1996 A
5573502 LeCocq et al. Nov 1996 A
5583280 Mo et al. Dec 1996 A
5584667 Davis Dec 1996 A
5584806 Amano Dec 1996 A
5586868 Lawless et al. Dec 1996 A
5590653 Aida et al. Jan 1997 A
5594786 Chaco et al. Jan 1997 A
5600073 Hill Feb 1997 A
5601420 Warner et al. Feb 1997 A
5609575 Larson et al. Mar 1997 A
5609576 Voss Mar 1997 A
5611784 Barresi et al. Mar 1997 A
5616124 Hague et al. Apr 1997 A
5620312 Hyman et al. Apr 1997 A
5620608 Rosa et al. Apr 1997 A
5626140 Feldman et al. May 1997 A
5626151 Linden May 1997 A
5626563 Dodge et al. May 1997 A
5627443 Kimura et al. May 1997 A
5628309 Brown May 1997 A
5628731 Dodge et al. May 1997 A
5630710 Tune et al. May 1997 A
5634896 Bryant et al. Jun 1997 A
5637095 Nason et al. Jun 1997 A
5640075 Brasseur et al. Jun 1997 A
5640150 Atwater Jun 1997 A
5643212 Coutre et al. Jul 1997 A
5648710 Ikeda Jul 1997 A
5649536 Ogura et al. Jul 1997 A
5651775 Walker et al. Jul 1997 A
5657000 Ellingboe Aug 1997 A
5658133 Anderson et al. Aug 1997 A
5658250 Blomquist et al. Aug 1997 A
5659234 Cresens Aug 1997 A
5661245 Svoboda et al. Aug 1997 A
5662612 Niehoff Sep 1997 A
5665065 Colman et al. Sep 1997 A
5669877 Blomquist Sep 1997 A
5672154 Sillén et al. Sep 1997 A
5672832 Cucci et al. Sep 1997 A
5681285 Ford et al. Oct 1997 A
5681286 Niehoff Oct 1997 A
5685844 Marttila Nov 1997 A
5687717 Halpern et al. Nov 1997 A
5689229 Chaco et al. Nov 1997 A
5691613 Gutwillinger Nov 1997 A
5695464 Viallet Dec 1997 A
5695473 Olsen Dec 1997 A
5697899 Hillman et al. Dec 1997 A
5697916 Schraga Dec 1997 A
5712795 Layman et al. Jan 1998 A
5713856 Eggers Feb 1998 A
5714691 Hill Feb 1998 A
5718562 Lawless et al. Feb 1998 A
5718569 Hoist Feb 1998 A
5720721 Dumas et al. Feb 1998 A
5722417 Rudolph Mar 1998 A
5728074 Castellano et al. Mar 1998 A
5728948 Bignell et al. Mar 1998 A
5733257 Stemby Mar 1998 A
5733259 Valcke et al. Mar 1998 A
5738659 Neer et al. Apr 1998 A
5743856 Oka et al. Apr 1998 A
5744027 Connell et al. Apr 1998 A
5744929 Miyazaki Apr 1998 A
5745378 Barker et al. Apr 1998 A
5752813 Tyner et al. May 1998 A
5752918 Fowler et al. May 1998 A
5752919 Schrimpf May 1998 A
5755691 Hilborne May 1998 A
5758643 Wong et al. Jun 1998 A
5761072 Bardsley, Jr. et al. Jun 1998 A
5764034 Bowman et al. Jun 1998 A
5766155 Hyman et al. Jun 1998 A
5772635 Dastur Jun 1998 A
5778256 Darbee Jul 1998 A
5781442 Engleson et al. Jul 1998 A
5782805 Meinzer Jul 1998 A
5788669 Peterson Aug 1998 A
5788674 McWilliams Aug 1998 A
5789923 Shimoyama et al. Aug 1998 A
5792069 Greenwald et al. Aug 1998 A
5793211 Shimoyama et al. Aug 1998 A
5795327 Wilson et al. Aug 1998 A
5798934 Saigo et al. Aug 1998 A
5800387 Duffy et al. Sep 1998 A
5803712 Davis et al. Sep 1998 A
5803917 Butterfield Sep 1998 A
5805455 Lipps Sep 1998 A
5807322 Lindsey et al. Sep 1998 A
5810770 Chin et al. Sep 1998 A
5813972 Nazarian et al. Sep 1998 A
5814004 Tamari Sep 1998 A
5814015 Gargano et al. Sep 1998 A
5816779 Lawless et al. Oct 1998 A
5822715 Worthington et al. Oct 1998 A
5827179 Lichter et al. Oct 1998 A
5827223 Butterfield Oct 1998 A
5832448 Brown Nov 1998 A
5836910 Duffy et al. Nov 1998 A
5841261 Nojima et al. Nov 1998 A
5841284 Takahashi Nov 1998 A
5843035 Bowman Dec 1998 A
5848971 Fowler et al. Dec 1998 A
5850344 Conkright Dec 1998 A
5857843 Leason et al. Jan 1999 A
5864330 Haynes Jan 1999 A
5865805 Ziemba Feb 1999 A
5867821 Ballantyne et al. Feb 1999 A
5871465 Vasko Feb 1999 A
5872453 Shimoyama et al. Feb 1999 A
5875195 Dixon Feb 1999 A
5882300 Malinouskas et al. Mar 1999 A
5882339 Beiser et al. Mar 1999 A
5885245 Lynch et al. Mar 1999 A
5889379 Yanagi et al. Mar 1999 A
5891051 Han et al. Apr 1999 A
5894209 Takagi et al. Apr 1999 A
5897493 Brown Apr 1999 A
5897498 Canfield, II et al. Apr 1999 A
5898292 Takemoto et al. Apr 1999 A
5899665 Makino et al. May 1999 A
5901150 Jhuboo et al. May 1999 A
5904666 Dedecker et al. May 1999 A
5904668 Hyman et al. May 1999 A
5905207 Schalk May 1999 A
5906598 Giesier May 1999 A
5910252 Truitt et al. Jun 1999 A
5915240 Karpf Jun 1999 A
5920263 Huttenhoff et al. Jul 1999 A
5923159 Ezell Jul 1999 A
5924074 Evans Jul 1999 A
5927349 Martucci Jul 1999 A
5932119 Kaplan et al. Aug 1999 A
5932987 McLoughlin Aug 1999 A
5935099 Peterson et al. Aug 1999 A
5935106 Olsen Aug 1999 A
5938634 Packard Aug 1999 A
5938636 Kramer et al. Aug 1999 A
5941846 Duffy et al. Aug 1999 A
5944660 Kimball et al. Aug 1999 A
5947911 Wong et al. Sep 1999 A
5954527 Jhuboo et al. Sep 1999 A
5954696 Ryan et al. Sep 1999 A
5956023 Lyle et al. Sep 1999 A
5956501 Brown Sep 1999 A
5957885 Bollish et al. Sep 1999 A
5957890 Mann et al. Sep 1999 A
5971594 Sahai et al. Oct 1999 A
5973497 Bergk et al. Oct 1999 A
5975081 Hood et al. Nov 1999 A
5989222 Cole et al. Nov 1999 A
5990838 Burns et al. Nov 1999 A
5991525 Shah et al. Nov 1999 A
5993393 Ryan et al. Nov 1999 A
5994876 Canny et al. Nov 1999 A
5997476 Brown Dec 1999 A
6000828 Leet Dec 1999 A
6003006 Colella et al. Dec 1999 A
6003388 Oeftering Dec 1999 A
6012034 Hamparian et al. Jan 2000 A
6017318 Gauthier et al. Jan 2000 A
6017493 Cambron Jan 2000 A
6021392 Lester et al. Feb 2000 A
6023977 Langdon et al. Feb 2000 A
6024539 Blomquist Feb 2000 A
6027441 Cantu Feb 2000 A
6032676 Moore Mar 2000 A
6033561 Schoendorfer Mar 2000 A
6036017 Bayliss, IV Mar 2000 A
6068612 Bowman May 2000 A
6068615 Brown et al. May 2000 A
6073106 Rozen et al. Jun 2000 A
6077246 Kullas et al. Jun 2000 A
6083206 Molko Jul 2000 A
6089104 Chang Jul 2000 A
6104295 Gaisser et al. Aug 2000 A
6110152 Kovelman Aug 2000 A
6110153 Davis Aug 2000 A
RE36871 Epstein et al. Sep 2000 E
6120459 Nitzan et al. Sep 2000 A
6122536 Sun et al. Sep 2000 A
6142008 Cole et al. Nov 2000 A
6150942 O'Brien Nov 2000 A
6157914 Seto et al. Dec 2000 A
6158288 Smith Dec 2000 A
6158965 Butterfield et al. Dec 2000 A
6159147 Lichter et al. Dec 2000 A
6159186 Wickham et al. Dec 2000 A
6164921 Moubayed et al. Dec 2000 A
6168561 Cantu Jan 2001 B1
6178827 Feller Jan 2001 B1
6182667 Hanks et al. Feb 2001 B1
6186141 Pike et al. Feb 2001 B1
6189105 Lopes Feb 2001 B1
6192752 Blaine Feb 2001 B1
6195589 Ketcham Feb 2001 B1
6202711 Martucci Mar 2001 B1
6203528 Deckert Mar 2001 B1
6208107 Maske et al. Mar 2001 B1
6212936 Meisberger Apr 2001 B1
6213972 Butterfield Apr 2001 B1
6231320 Lawless et al. May 2001 B1
6234176 Domae et al. May 2001 B1
6236326 Murphy et al. May 2001 B1
6237398 Porat et al. May 2001 B1
6241704 Peterson et al. Jun 2001 B1
6248067 Causey, III et al. Jun 2001 B1
6250132 Drzewiecki Jun 2001 B1
6259355 Chaco et al. Jul 2001 B1
6259587 Sheldon et al. Jul 2001 B1
6261065 Nayak Jul 2001 B1
6262946 Khuri-Yakub et al. Jul 2001 B1
6267559 Mossman et al. Jul 2001 B1
6267725 Dubberstein et al. Jul 2001 B1
6269340 Ford et al. Jul 2001 B1
6270455 Brown Aug 2001 B1
6271813 Palalau Aug 2001 B1
6277072 Bardy Aug 2001 B1
6277099 Strowe et al. Aug 2001 B1
6280380 Bardy Aug 2001 B1
6280391 Olson et al. Aug 2001 B1
6280408 Sipin Aug 2001 B1
6283761 Joao Sep 2001 B1
6285155 Maske et al. Sep 2001 B1
6312378 Bardy Nov 2001 B1
6322516 Masuda et al. Nov 2001 B1
6330351 Yasunaga Dec 2001 B1
6337675 Toffolo et al. Jan 2002 B1
6345539 Rawes et al. Feb 2002 B1
6347553 Morris et al. Feb 2002 B1
6349740 Cho et al. Feb 2002 B1
6358225 Butterfield Mar 2002 B1
6358387 Kopf-Sill et al. Mar 2002 B1
6362591 Moberg Mar 2002 B1
6385505 Lipps May 2002 B1
6386050 Yin et al. May 2002 B1
6394958 Bratteli et al. May 2002 B1
6396583 Clare May 2002 B1
6398760 Danby Jun 2002 B1
6405076 Taylor et al. Jun 2002 B1
6408679 Kline-Schoder et al. Jun 2002 B1
6413238 Maget Jul 2002 B1
6416291 Butterfield et al. Jul 2002 B1
6418334 Unger et al. Jul 2002 B1
6418535 Kulakowski et al. Jul 2002 B1
6445053 Cho Sep 2002 B1
6456245 Crawford Sep 2002 B1
6457346 Kline-Schoder et al. Oct 2002 B1
6463785 Kline-Schoder et al. Oct 2002 B1
6467331 Kline-Schoder et al. Oct 2002 B1
6468242 Wilson et al. Oct 2002 B1
6475178 Krajewski Nov 2002 B1
6481980 Vandlik Nov 2002 B1
6482158 Mault Nov 2002 B2
6482185 Hartmann Nov 2002 B1
6485263 Bryant et al. Nov 2002 B1
6485418 Yasushi et al. Nov 2002 B2
6485465 Moberg et al. Nov 2002 B2
6487916 Gomm et al. Dec 2002 B1
6489896 Platt Dec 2002 B1
6494694 Lawless et al. Dec 2002 B2
6494831 Koritzinsky Dec 2002 B1
6497680 Holst et al. Dec 2002 B1
6503221 Briggs Jan 2003 B1
6512944 Kovtun et al. Jan 2003 B1
6516667 Broad et al. Feb 2003 B1
6517482 Eiden et al. Feb 2003 B1
6519569 White et al. Feb 2003 B1
6529751 Van Driel et al. Mar 2003 B1
6531708 Malmstrom Mar 2003 B1
6539315 Adams et al. Mar 2003 B1
6540672 Simonsen et al. Apr 2003 B1
6544212 Galley et al. Apr 2003 B2
6544228 Heitmeier Apr 2003 B1
6558125 Futterknecht May 2003 B1
6558351 Steil et al. May 2003 B1
6562012 Brown et al. May 2003 B1
6564825 Lowery et al. May 2003 B2
6565509 Say et al. May 2003 B1
6568416 Tucker et al. May 2003 B2
6572542 Houben et al. Jun 2003 B1
6572545 Knobbe et al. Jun 2003 B2
6572576 Brugger et al. Jun 2003 B2
6578422 Lam et al. Jun 2003 B2
6578435 Gould et al. Jun 2003 B2
6581117 Klein et al. Jun 2003 B1
RE38189 Walker et al. Jul 2003 E
6585675 O'Mahony et al. Jul 2003 B1
6589229 Connelly et al. Jul 2003 B1
6589792 Malachowski Jul 2003 B1
6599281 Struys et al. Jul 2003 B1
6599282 Burko Jul 2003 B2
6602191 Quy Aug 2003 B2
6605072 Struys et al. Aug 2003 B2
6609047 Lipps Aug 2003 B1
6615674 Ohnishi Sep 2003 B2
6616633 Butterfield et al. Sep 2003 B1
6617564 Ockerse et al. Sep 2003 B2
6618916 Eberle et al. Sep 2003 B1
6622542 Derek Sep 2003 B2
6622561 Lam et al. Sep 2003 B2
D481121 Evans Oct 2003 S
6629449 Kline-Schoder et al. Oct 2003 B1
6634233 He Oct 2003 B2
6640246 Gardy, Jr. et al. Oct 2003 B1
6641533 Causey, III et al. Nov 2003 B2
6641541 Lovett et al. Nov 2003 B1
6648861 Platt et al. Nov 2003 B2
6652455 Kocher Nov 2003 B1
6653937 Nelson et al. Nov 2003 B2
6659980 Moberg et al. Dec 2003 B2
D485356 Evans Jan 2004 S
6685668 Cho et al. Feb 2004 B1
6685678 Evans et al. Feb 2004 B2
6689069 Bratteli et al. Feb 2004 B2
6689091 Bui et al. Feb 2004 B2
6692241 Watanabe et al. Feb 2004 B2
6716004 Vandlik Apr 2004 B2
6719535 Rakestraw et al. Apr 2004 B2
6721582 Trepagnier et al. Apr 2004 B2
6722211 Ciobanu et al. Apr 2004 B1
6725200 Rost Apr 2004 B1
6725721 Venczel Apr 2004 B2
6731989 Engleson et al. May 2004 B2
6732595 Lynnworth May 2004 B2
6738052 Manke et al. May 2004 B1
6740072 Starkweather et al. May 2004 B2
6741212 Kralovec et al. May 2004 B2
6748808 Lam et al. Jun 2004 B2
6749403 Bryant et al. Jun 2004 B2
6752787 Causey, III et al. Jun 2004 B1
6753842 Williams et al. Jun 2004 B1
6759007 Westberg Jul 2004 B1
6760643 Lipps Jul 2004 B2
6768920 Lange Jul 2004 B2
6773412 O'Mahony Aug 2004 B2
6780156 Haueter et al. Aug 2004 B2
6783328 Lucke et al. Aug 2004 B2
6785573 Kovtun et al. Aug 2004 B2
6786885 Hochman et al. Sep 2004 B2
6789426 Yaralioglu et al. Sep 2004 B2
6790198 White et al. Sep 2004 B1
6793625 Cavallaro et al. Sep 2004 B2
6801227 Bocionek et al. Oct 2004 B2
6805671 Stergiopoulos et al. Oct 2004 B2
6807965 Hickle Oct 2004 B1
6809653 Mann et al. Oct 2004 B1
6813964 Clark et al. Nov 2004 B1
6814547 Childers Nov 2004 B2
6824528 Faries Nov 2004 B1
6830558 Flaherty et al. Dec 2004 B2
6840113 Fukumura et al. Jan 2005 B2
6846161 Kline Jan 2005 B2
6852094 Beck Feb 2005 B2
6852104 Blomquist Feb 2005 B2
6854338 Khuri-Yakub et al. Feb 2005 B2
6857318 Silber et al. Feb 2005 B1
6869425 Briggs et al. Mar 2005 B2
6873268 Lebel et al. Mar 2005 B2
6883376 He Apr 2005 B2
6885881 Leonhardt Apr 2005 B2
6887216 Hochman et al. May 2005 B2
6898301 Iwanaga May 2005 B2
6907361 Molenaar Jun 2005 B2
6907792 Ohnishi Jun 2005 B2
6915170 Engleson et al. Jul 2005 B2
6920795 Bischoff et al. Jul 2005 B2
6923763 Kovatchev et al. Aug 2005 B1
6928338 Buchser et al. Aug 2005 B1
6929619 Fago et al. Aug 2005 B2
6929751 Bowman Aug 2005 B2
6932114 Sparks Aug 2005 B2
6932796 Sage et al. Aug 2005 B2
6935192 Sobek et al. Aug 2005 B2
6936029 Mann et al. Aug 2005 B2
6941005 Lary et al. Sep 2005 B2
6942636 Mendez Sep 2005 B2
6945954 Hochman et al. Sep 2005 B2
6958705 Lebel et al. Oct 2005 B2
6964204 Clark et al. Nov 2005 B2
6973374 Ader Dec 2005 B2
6974437 Lebel et al. Dec 2005 B2
6975922 Duncan et al. Dec 2005 B2
6978779 Haveri et al. Dec 2005 B2
6979326 Mann et al. Dec 2005 B2
6981960 Cho et al. Jan 2006 B2
6984218 Nayak et al. Jan 2006 B2
6985768 Hemming et al. Jan 2006 B2
6985870 Martucci et al. Jan 2006 B2
6986347 Hickle Jan 2006 B2
6986753 Bui Jan 2006 B2
6997905 Gillespie, Jr. et al. Feb 2006 B2
6997920 Mann et al. Feb 2006 B2
7006005 Nazarian et al. Feb 2006 B2
7017623 Tribble et al. Mar 2006 B2
7021148 Kuhn Apr 2006 B2
7025743 Mann et al. Apr 2006 B2
7029455 Flaherty Apr 2006 B2
7029456 Ware et al. Apr 2006 B2
7059184 Kanouola et al. Jun 2006 B2
7060059 Keith et al. Jun 2006 B2
7069793 Ishikawa et al. Jul 2006 B2
7072725 Bristol et al. Jul 2006 B2
7074209 Evans et al. Jul 2006 B2
7080557 Adnan Jul 2006 B2
7082843 Clark et al. Aug 2006 B2
7087444 Wong et al. Aug 2006 B2
7092796 Vanderveen Aug 2006 B2
7092797 Gaines et al. Aug 2006 B2
7093502 Kupnik et al. Aug 2006 B2
7096729 Repko et al. Aug 2006 B2
7103419 Engleson et al. Sep 2006 B2
7104763 Bouton et al. Sep 2006 B2
7104769 Davis Sep 2006 B2
7108680 Rohr et al. Sep 2006 B2
7109878 Mann et al. Sep 2006 B2
7115113 Evans et al. Oct 2006 B2
7117041 Engleson et al. Oct 2006 B2
7137964 Flaherty Nov 2006 B2
7141037 Butterfield et al. Nov 2006 B2
7152490 Freund, Jr. et al. Dec 2006 B1
7154397 Zerhusen et al. Dec 2006 B2
7161488 Frasch Jan 2007 B2
7162290 Levin Jan 2007 B1
7162927 Selvan et al. Jan 2007 B1
7171277 Engleson et al. Jan 2007 B2
7174789 Orr et al. Feb 2007 B2
7185288 McKeever Feb 2007 B2
7197943 Lee et al. Apr 2007 B2
7201734 Hickle Apr 2007 B2
7204823 Estes et al. Apr 2007 B2
7206715 Vanderveen et al. Apr 2007 B2
7213009 Pestotnik May 2007 B2
7220240 Struys et al. May 2007 B2
7229430 Hickle et al. Jun 2007 B2
7230529 Ketcherside Jun 2007 B2
7232430 Carlisle Jun 2007 B2
7238164 Childers et al. Jul 2007 B2
7247154 Hickle Jul 2007 B2
7253779 Greer et al. Aug 2007 B2
7254425 Lowery et al. Aug 2007 B2
7258534 Fathallah et al. Aug 2007 B2
7267664 Rizzo Sep 2007 B2
7267665 Steil et al. Sep 2007 B2
7272529 Hogan et al. Sep 2007 B2
7278983 Ireland et al. Oct 2007 B2
7291123 Baraldi et al. Nov 2007 B2
7293461 Gimdt Nov 2007 B1
7294109 Lovett et al. Nov 2007 B2
7296482 Schaffer et al. Nov 2007 B2
7300418 Zaleski Nov 2007 B2
7305883 Khuri-Yakub et al. Dec 2007 B2
7327273 Hung et al. Feb 2008 B2
7338470 Katz Mar 2008 B2
7347836 Peterson et al. Mar 2008 B2
7347854 Shelton et al. Mar 2008 B2
7354420 Steil et al. Apr 2008 B2
7356382 Vanderveen Apr 2008 B2
7360999 Nelson et al. Apr 2008 B2
7364562 Braig et al. Apr 2008 B2
7367942 Grage et al. May 2008 B2
7369948 Ferenczi et al. May 2008 B1
7384410 Eggers et al. Jun 2008 B2
7397166 Morgan et al. Jul 2008 B1
7398183 Holland et al. Jul 2008 B2
7399277 Saidara et al. Jul 2008 B2
7402153 Steil et al. Jul 2008 B2
7402154 Mendez Jul 2008 B2
7407489 Mendez Aug 2008 B2
7414534 Kroll et al. Aug 2008 B1
7415895 Kurisaki et al. Aug 2008 B2
7426443 Simon Sep 2008 B2
7430675 Lee et al. Sep 2008 B2
7447566 Knauper et al. Nov 2008 B2
7447643 Olson Nov 2008 B1
7452190 Bouton et al. Nov 2008 B2
7454314 Holland et al. Nov 2008 B2
7471994 Ford et al. Dec 2008 B2
7482818 Greenwald et al. Jan 2009 B2
7483756 Engleson et al. Jan 2009 B2
7490021 Holland et al. Feb 2009 B2
7491187 Van Den Berghe et al. Feb 2009 B2
7503903 Carlisle et al. Mar 2009 B2
7517332 Tonelli et al. Apr 2009 B2
7523401 Aldridge Apr 2009 B1
7545075 Huang et al. Jun 2009 B2
7556616 Fathallah et al. Jul 2009 B2
7561986 Vanderveen et al. Jul 2009 B2
7571024 Duncan et al. Aug 2009 B2
7645258 White et al. Jan 2010 B2
7654127 Krulevitch et al. Feb 2010 B2
7657443 Crass Feb 2010 B2
7668731 Martucci et al. Feb 2010 B2
7678048 Urbano et al. Mar 2010 B1
7693697 Westenkow et al. Apr 2010 B2
7699806 Ware et al. Apr 2010 B2
7705727 Pestotnik Apr 2010 B2
7766873 Moberg et al. Aug 2010 B2
7775126 Eckhardt Aug 2010 B2
7775127 Wade Aug 2010 B2
7785284 Baralsi et al. Aug 2010 B2
7785313 Mastrototaro Aug 2010 B2
7786909 Udupa et al. Aug 2010 B2
7806886 Kanderian, Jr. et al. Oct 2010 B2
7826981 Goode, Jr. et al. Nov 2010 B2
7847276 Carlisle Dec 2010 B2
7860583 Condurso et al. Dec 2010 B2
7871394 Halbert et al. Jan 2011 B2
7876443 Bernacki Jan 2011 B2
7895053 Holland et al. Feb 2011 B2
7895882 Carlisle Mar 2011 B2
7896834 Smisson, III Mar 2011 B2
7896842 Palmroos et al. Mar 2011 B2
7905710 Wang et al. Mar 2011 B2
7933780 de la Huerga Apr 2011 B2
7945452 Fathallah et al. May 2011 B2
7981073 Mollstam Jul 2011 B2
7981082 Wang et al. Jul 2011 B2
8002736 Patrick et al. Aug 2011 B2
8034020 Dewey Oct 2011 B2
8038593 Friedman et al. Oct 2011 B2
8065161 Howard et al. Nov 2011 B2
8067760 Carlisle Nov 2011 B2
8075546 Carlisle et al. Dec 2011 B2
8078983 Davis et al. Dec 2011 B2
8121857 Galasso et al. Feb 2012 B2
8149131 Blornquist Apr 2012 B2
8175668 Nabutovsky et al. May 2012 B1
8177739 Cartledge et al. May 2012 B2
8185322 Schroeder et al. May 2012 B2
8219413 Martinez et al. Jul 2012 B2
8221395 Shelton et al. Jul 2012 B2
8226597 Jacobson et al. Jul 2012 B2
8231578 Fathallah et al. Jul 2012 B2
8234128 Martucci et al. Jul 2012 B2
8271106 Wehba et al. Sep 2012 B2
8287514 Miller et al. Oct 2012 B2
8291337 Gannin et al. Oct 2012 B2
8313308 Lawless et al. Nov 2012 B2
8317698 Lowery Nov 2012 B2
8317750 Ware et al. Nov 2012 B2
8317752 Cozmi et al. Nov 2012 B2
8318094 Bayandorian et al. Nov 2012 B1
8340792 Condurso et al. Dec 2012 B2
8347731 Genosar Jan 2013 B2
8359338 Butterfield et al. Jan 2013 B2
8361021 Wang et al. Jan 2013 B2
8378837 Wang et al. Feb 2013 B2
8388598 Steinkogler Mar 2013 B2
8398616 Budiman Mar 2013 B2
8403908 Jacobson et al. Mar 2013 B2
8449524 Braig et al. May 2013 B2
8477307 Yufa et al. Jul 2013 B1
8494879 Davis et al. Jul 2013 B2
8504179 Blomquist Aug 2013 B2
8517990 Teel, IV et al. Aug 2013 B2
8518021 Stewart et al. Aug 2013 B2
8523797 Lowery et al. Sep 2013 B2
8539812 Stringham et al. Sep 2013 B2
8543416 Palmroos et al. Sep 2013 B2
8577692 Silkaitis et al. Nov 2013 B2
8622990 Estes et al. Jan 2014 B2
8630722 Condurso et al. Jan 2014 B2
8665214 Forutanpour et al. Mar 2014 B2
8666769 Butler et al. Mar 2014 B2
8700421 Feng et al. Apr 2014 B2
8706233 Su et al. Apr 2014 B2
8721584 Braithwaite et al. May 2014 B2
8761906 Condurso et al. Jun 2014 B2
8768719 Wehba et al. Jul 2014 B2
8771251 Ruchti et al. Jul 2014 B2
8792981 Yudovsky et al. Jul 2014 B2
8821432 Unverdorben Sep 2014 B2
8823382 Rondoni et al. Sep 2014 B2
8857269 Johnson et al. Oct 2014 B2
8858185 Johnson et al. Oct 2014 B2
8964185 Luo et al. Feb 2015 B1
9005150 Ware et al. Apr 2015 B2
9026370 Rubalcaba et al. May 2015 B2
9084855 Ware et al. Jul 2015 B2
9114217 Sur et al. Aug 2015 B2
9134735 Lowery et al. Sep 2015 B2
9134736 Lowery et al. Sep 2015 B2
9138526 Ware et al. Sep 2015 B2
9190010 Vik et al. Nov 2015 B2
9240002 Hume et al. Jan 2016 B2
9272089 Jacobson et al. Mar 2016 B2
9333291 Jacobson et al. May 2016 B2
9381296 Arrizza et al. Jul 2016 B2
9393362 Cozmi et al. Jul 2016 B2
9468718 Hung et al. Oct 2016 B2
9498583 Sur et al. Nov 2016 B2
9707341 Dumas et al. Jul 2017 B2
9764087 Peterfreund et al. Sep 2017 B2
9852265 Treacy et al. Dec 2017 B1
9943269 Muhsin et al. Apr 2018 B2
9995611 Ruchti et al. Jun 2018 B2
10022498 Ruchti et al. Jul 2018 B2
10046112 Oruklu et al. Aug 2018 B2
10089055 Fryman Oct 2018 B1
10166328 Oruklu et al. Jan 2019 B2
10342917 Shubinsky et al. Jul 2019 B2
10430761 Hume et al. Oct 2019 B2
20010007636 Butterfield Jul 2001 A1
20010014769 Bufe et al. Aug 2001 A1
20010015099 Blaine Aug 2001 A1
20010016056 Westphal et al. Aug 2001 A1
20010032099 Joao Oct 2001 A1
20010037060 Thompson et al. Nov 2001 A1
20010041869 Causey et al. Nov 2001 A1
20010044731 Coffman et al. Nov 2001 A1
20020003892 Iwanaga Jan 2002 A1
20020007116 Zatezalo et al. Jan 2002 A1
20020013545 Soltanpour et al. Jan 2002 A1
20020013551 Zaitsu et al. Jan 2002 A1
20020015018 Shimazu et al. Feb 2002 A1
20020018720 Carlisle et al. Feb 2002 A1
20020029776 Blomquist Mar 2002 A1
20020031838 Meinhart et al. Mar 2002 A1
20020032583 Joao Mar 2002 A1
20020038392 De La Huerga Mar 2002 A1
20020040208 Flaherty et al. Apr 2002 A1
20020044059 Reeder et al. Apr 2002 A1
20020045806 Baker, Jr. et al. Apr 2002 A1
20020082728 Mueller et al. Jun 2002 A1
20020083771 Khuri-Yakub et al. Jul 2002 A1
20020085952 Ellingboe Jul 2002 A1
20020087115 Hartlaub Jul 2002 A1
20020095486 Bahl Jul 2002 A1
20020099282 Knobbe et al. Jul 2002 A1
20020099334 Hanson et al. Jul 2002 A1
20020143580 Bristol et al. Oct 2002 A1
20020147389 Cavallaro et al. Oct 2002 A1
20020152239 Bautista-Lloyd et al. Oct 2002 A1
20020168278 Jeon et al. Nov 2002 A1
20020173703 Lebel et al. Nov 2002 A1
20020183693 Peterson et al. Dec 2002 A1
20030009244 Engleson Jan 2003 A1
20030013959 Grunwald et al. Jan 2003 A1
20030018308 Tsai Jan 2003 A1
20030025602 Medema et al. Feb 2003 A1
20030028082 Thompson Feb 2003 A1
20030030001 Cooper et al. Feb 2003 A1
20030045840 Burko Mar 2003 A1
20030050621 Lebel et al. Mar 2003 A1
20030060688 Ciarniello et al. Mar 2003 A1
20030060765 Campbell et al. Mar 2003 A1
20030065537 Evans Apr 2003 A1
20030065589 Giacchetti Apr 2003 A1
20030073954 Moberg et al. Apr 2003 A1
20030079746 Hickle May 2003 A1
20030083583 Kovtun et al. May 2003 A1
20030091442 Bush et al. May 2003 A1
20030104982 Wittmann et al. Jun 2003 A1
20030106553 Vanderveen Jun 2003 A1
20030125662 Bui Jul 2003 A1
20030130616 Steil Jul 2003 A1
20030135087 Hickle Jul 2003 A1
20030136193 Fujimoto Jul 2003 A1
20030139701 White et al. Jul 2003 A1
20030140928 Bui et al. Jul 2003 A1
20030141981 Bui Jul 2003 A1
20030143746 Sage, Jr. Jul 2003 A1
20030144878 Wilkes et al. Jul 2003 A1
20030158508 Digianfilippo Aug 2003 A1
20030160683 Blomquist Aug 2003 A1
20030163789 Blomquist Aug 2003 A1
20030173408 Mosher, Jr. et al. Sep 2003 A1
20030186833 Huff et al. Oct 2003 A1
20030187338 Say et al. Oct 2003 A1
20030200116 Forrester Oct 2003 A1
20030204274 Ullestad et al. Oct 2003 A1
20030204416 Acharya Oct 2003 A1
20030212364 Mann et al. Nov 2003 A1
20030212379 Bylund et al. Nov 2003 A1
20030216682 Junker Nov 2003 A1
20030217962 Childers et al. Nov 2003 A1
20030233071 Gillespie, Jr. et al. Dec 2003 A1
20040030277 O'Mahony et al. Feb 2004 A1
20040047736 Nose et al. Mar 2004 A1
20040057226 Berthou et al. Mar 2004 A1
20040064342 Browne et al. Apr 2004 A1
20040073125 Lovett et al. Apr 2004 A1
20040073161 Tachibana Apr 2004 A1
20040077996 Jasperson et al. Apr 2004 A1
20040082908 Whitehurst Apr 2004 A1
20040082918 Evans et al. Apr 2004 A1
20040104271 Martucci et al. Jun 2004 A1
20040119753 Zencke Jun 2004 A1
20040120825 Bouton et al. Jun 2004 A1
20040145114 Ippolito et al. Jun 2004 A1
20040128162 Schlotterbeck et al. Jul 2004 A1
20040133166 Moberg et al. Jul 2004 A1
20040147034 Gore et al. Jul 2004 A1
20040149823 Aptekar Aug 2004 A1
20040152970 Hunter et al. Aug 2004 A1
20040158193 Bui et al. Aug 2004 A1
20040167464 Ireland et al. Aug 2004 A1
20040167465 Kohler Aug 2004 A1
20040167804 Simpson Aug 2004 A1
20040172222 Simpson et al. Sep 2004 A1
20040172283 Vanderveen Sep 2004 A1
20040172289 Kozic et al. Sep 2004 A1
20040172302 Martucci et al. Sep 2004 A1
20040176984 White et al. Sep 2004 A1
20040181314 Zaleski Sep 2004 A1
20040193025 Steil et al. Sep 2004 A1
20040193325 Bonderud Sep 2004 A1
20040193328 Butterfield et al. Sep 2004 A1
20040193453 Butterfield et al. Sep 2004 A1
20040204638 Diab et al. Oct 2004 A1
20040204673 Flaherty et al. Oct 2004 A1
20040220517 Starkweather et al. Nov 2004 A1
20040225252 Gillespie et al. Nov 2004 A1
20040225409 Duncan et al. Nov 2004 A1
20040232219 Fowler Nov 2004 A1
20040247445 Nelson Dec 2004 A1
20040253123 Xie et al. Dec 2004 A1
20040254434 Goodnow et al. Dec 2004 A1
20040254513 Shang et al. Dec 2004 A1
20050021006 Tonnies Jan 2005 A1
20050021297 Hartlaub Jan 2005 A1
20050022274 Campbell et al. Jan 2005 A1
20050038680 McMahon Feb 2005 A1
20050055242 Bello et al. Mar 2005 A1
20050055244 Mullan et al. Mar 2005 A1
20050065465 Lebel et al. Mar 2005 A1
20050075544 Shapiro et al. Apr 2005 A1
20050096593 Pope et al. May 2005 A1
20050099624 Staehr May 2005 A1
20050107923 Vanderveen May 2005 A1
20050119914 Batch Jun 2005 A1
20050131739 Rabinowitz et al. Jun 2005 A1
20050137522 Aoki Jun 2005 A1
20050143864 Blomquist Jun 2005 A1
20050144043 Holland et al. Jun 2005 A1
20050145010 Vanderveen et al. Jul 2005 A1
20050171503 Van Den Berghe et al. Aug 2005 A1
20050171815 Vanderveen Aug 2005 A1
20050177045 Degertekin et al. Aug 2005 A1
20050177096 Bollish et al. Aug 2005 A1
20050182306 Sloan Aug 2005 A1
20050182355 Bui Aug 2005 A1
20050182366 Vogt et al. Aug 2005 A1
20050187515 Varrichio et al. Aug 2005 A1
20050192529 Butterfield et al. Sep 2005 A1
20050192557 Brauker et al. Sep 2005 A1
20050197554 Polcha Sep 2005 A1
20050197621 Poulsen et al. Sep 2005 A1
20050209563 Hopping et al. Sep 2005 A1
20050209793 Yamada Sep 2005 A1
20050224083 Crass Oct 2005 A1
20050235732 Rush Oct 2005 A1
20050235733 Hoist et al. Oct 2005 A1
20050238497 Hoist et al. Oct 2005 A1
20050238506 Mescher et al. Oct 2005 A1
20050240305 Bogash et al. Oct 2005 A1
20050273059 Mernoe et al. Dec 2005 A1
20050277890 Stewart et al. Dec 2005 A1
20050279419 Tribble et al. Dec 2005 A1
20060002799 Schann et al. Jan 2006 A1
20060009727 O'Mahony et al. Jan 2006 A1
20060009734 Martin Jan 2006 A1
20060042633 Bishop et al. Mar 2006 A1
20060047270 Shelton Mar 2006 A1
20060047538 Condurso et al. Mar 2006 A1
20060053036 Coffman et al. Mar 2006 A1
20060064020 Burnes et al. Mar 2006 A1
20060064053 Bollish et al. Mar 2006 A1
20060079768 Small et al. Apr 2006 A1
20060079831 Gilbert Apr 2006 A1
20060100746 Leibner-Druska May 2006 A1
20060100907 Holland et al. May 2006 A1
20060106649 Eggers et al. May 2006 A1
20060116639 Russell Jun 2006 A1
20060117856 Orr et al. Jun 2006 A1
20060117867 Froehlich et al. Jun 2006 A1
20060122867 Eggers et al. Jun 2006 A1
20060135939 Brown Jun 2006 A1
20060135940 Joshi Jun 2006 A1
20060136271 Eggers et al. Jun 2006 A1
20060140798 Kutsuzawa Jun 2006 A1
20060143051 Eggers et al. Jun 2006 A1
20060173260 Gaoni et al. Aug 2006 A1
20060173406 Hayes et al. Aug 2006 A1
20060180916 Wyland Aug 2006 A1
20060181695 Sage, Jr. Aug 2006 A1
20060187069 Duan Aug 2006 A1
20060190302 Eggers et al. Aug 2006 A1
20060195022 Trepagnier et al. Aug 2006 A1
20060200007 Brockway et al. Sep 2006 A1
20060200369 Batch et al. Sep 2006 A1
20060211404 Cromp et al. Sep 2006 A1
20060224140 Junker Oct 2006 A1
20060224141 Rush et al. Oct 2006 A1
20060224181 McEwen et al. Oct 2006 A1
20060226088 Robinson et al. Oct 2006 A1
20060226089 Robinson et al. Oct 2006 A1
20060226090 Robinson et al. Oct 2006 A1
20060229551 Martinez Oct 2006 A1
20060229557 Fathallah et al. Oct 2006 A1
20060229918 Fotsch et al. Oct 2006 A1
20060235353 Gelfand et al. Oct 2006 A1
20060258985 Russell Nov 2006 A1
20060260416 Sage et al. Nov 2006 A1
20060264895 Flanders Nov 2006 A1
20060265246 Hoag Nov 2006 A1
20060266128 Clark et al. Nov 2006 A1
20060270971 Gelfand et al. Nov 2006 A1
20060271286 Rosenberg Nov 2006 A1
20060272421 Frinak et al. Dec 2006 A1
20060275142 Bouton et al. Dec 2006 A1
20070015972 Wang et al. Jan 2007 A1
20070036511 Lundquist et al. Feb 2007 A1
20070060796 Kim Mar 2007 A1
20070060871 Istoc Mar 2007 A1
20070060872 Hall et al. Mar 2007 A1
20070060874 Nesbitt et al. Mar 2007 A1
20070062250 Krulevitch et al. Mar 2007 A1
20070065363 Dalal et al. Mar 2007 A1
20070078314 Grounsell Apr 2007 A1
20070083152 Williams, Jr. et al. Apr 2007 A1
20070084288 Thomas et al. Apr 2007 A1
20070088271 Richards Apr 2007 A1
20070088333 Levin et al. Apr 2007 A1
20070093753 Krulevitcvh et al. Apr 2007 A1
20070100222 Mastrototaro et al. May 2007 A1
20070100665 Brown May 2007 A1
20070112298 Mueller et al. May 2007 A1
20070118405 Campbell et al. May 2007 A1
20070129618 Goldberger et al. Jun 2007 A1
20070142822 Remde Jun 2007 A1
20070156452 Batch Jul 2007 A1
20070179436 Braig et al. Aug 2007 A1
20070191817 Martin Aug 2007 A1
20070213598 Howard et al. Sep 2007 A1
20070214003 Holland et al. Sep 2007 A1
20070215545 Bissler et al. Sep 2007 A1
20070233035 Wehba et al. Oct 2007 A1
20070233049 Wehba et al. Oct 2007 A1
20070240497 Robinson et al. Oct 2007 A1
20070255250 Moberg et al. Nov 2007 A1
20070257788 Carlson Nov 2007 A1
20070267945 Sudol Nov 2007 A1
20070270747 Remde Nov 2007 A1
20070274843 Vanderveen et al. Nov 2007 A1
20070289384 Sakai et al. Dec 2007 A1
20080009684 Corsetti et al. Jan 2008 A1
20080028868 Konzelmann et al. Feb 2008 A1
20080033361 Evans et al. Feb 2008 A1
20080039777 Katz et al. Feb 2008 A1
20080048211 Khuri-Yakub et al. Feb 2008 A1
20080058773 John Mar 2008 A1
20080060448 Wiest et al. Mar 2008 A1
20080065420 Tirinato et al. Mar 2008 A1
20080071210 Moubayed et al. Mar 2008 A1
20080071496 Glascock Mar 2008 A1
20080071580 Marcus et al. Mar 2008 A1
20080091466 Butler et al. Apr 2008 A1
20080097288 Levin et al. Apr 2008 A1
20080097289 Steil et al. Apr 2008 A1
20080097317 Alholm et al. Apr 2008 A1
20080098798 Riley et al. May 2008 A1
20080119822 Knauper May 2008 A1
20080125701 Moberg et al. May 2008 A1
20080139907 Rao et al. Jun 2008 A1
20080145249 Smisson Jun 2008 A1
20080172030 Blomquist et al. Jul 2008 A1
20080177254 Shelton et al. Jul 2008 A1
20080184784 Dam Aug 2008 A1
20080188789 Galavotti et al. Aug 2008 A1
20080188796 Steil et al. Aug 2008 A1
20080200870 Palmroos et al. Aug 2008 A1
20080208484 Butterfield et al. Aug 2008 A1
20080214919 Harmon et al. Sep 2008 A1
20080221521 Getz et al. Sep 2008 A1
20080221522 Moberg et al. Sep 2008 A1
20080243055 Fathallah et al. Oct 2008 A1
20080262469 Bristol et al. Oct 2008 A1
20080269663 Arnold et al. Oct 2008 A1
20080269714 Mastrototaro et al. Oct 2008 A1
20080269723 Mastrototaro et al. Oct 2008 A1
20080275384 Mastrototaro et al. Nov 2008 A1
20080300572 Rankers et al. Dec 2008 A1
20090001908 Shubinsky et al. Jan 2009 A1
20090005703 Fasciano Jan 2009 A1
20090006061 Thukral et al. Jan 2009 A1
20090006129 Thukral Jan 2009 A1
20090006133 Weinert Jan 2009 A1
20090015824 Shubinsky et al. Jan 2009 A1
20090043171 Rule Feb 2009 A1
20090054743 Stewart Feb 2009 A1
20090054754 McMahon et al. Feb 2009 A1
20090069743 Krishnamoorthy et al. Mar 2009 A1
20090077248 Castellucci et al. Mar 2009 A1
20090082676 Bennison Mar 2009 A1
20090088731 Campbell et al. Apr 2009 A1
20090097029 Tokhtuev et al. Apr 2009 A1
20090112155 Zhao Apr 2009 A1
20090124963 Hogard et al. May 2009 A1
20090124964 Leach et al. May 2009 A1
20090131861 Braig et al. May 2009 A1
20090135196 Holland et al. May 2009 A1
20090143726 Bouton et al. Jun 2009 A1
20090144025 Bouton et al. Jun 2009 A1
20090144026 Bouton et al. Jun 2009 A1
20090149743 Barron et al. Jun 2009 A1
20090156922 Goldberger et al. Jun 2009 A1
20090156975 Robinson et al. Jun 2009 A1
20090171289 Davis et al. Jul 2009 A1
20090177146 Nesbitt et al. Jul 2009 A1
20090177188 Steinkogler Jul 2009 A1
20090177248 Roberts Jul 2009 A1
20090177769 Roberts Jul 2009 A1
20090177992 Rubalcaba, Jr. Jul 2009 A1
20090178485 Thomas et al. Jul 2009 A1
20090183147 Davis et al. Jul 2009 A1
20090192367 Braig et al. Jul 2009 A1
20090205426 Balschat et al. Aug 2009 A1
20090209938 Aalto-Setala Aug 2009 A1
20090209945 Lobl et al. Aug 2009 A1
20090212966 Panduro Aug 2009 A1
20090221890 Saffer et al. Sep 2009 A1
20090223294 Thomas et al. Sep 2009 A1
20090227939 Memoe et al. Sep 2009 A1
20090264720 Torjman et al. Oct 2009 A1
20090270810 Debelser Oct 2009 A1
20090270833 Debelser Oct 2009 A1
20100022988 Wochner Jan 2010 A1
20100280430 Caleffi et al. Jan 2010 A1
20100036310 Hillman Feb 2010 A1
20100056992 Hayter Mar 2010 A1
20100069892 Steinbach et al. Mar 2010 A1
20100077866 Graboi et al. Apr 2010 A1
20100079760 Bernacki Apr 2010 A1
20100094251 Estes et al. Apr 2010 A1
20100106082 Zhou Apr 2010 A1
20100114027 Jacobson et al. May 2010 A1
20100121170 Rule May 2010 A1
20100121415 Skelton et al. May 2010 A1
20100130933 Holland et al. May 2010 A1
20100131434 Magent et al. May 2010 A1
20100141460 Tokhtuev et al. Jun 2010 A1
20100147081 Thomas et al. Jun 2010 A1
20100152554 Steine et al. Jun 2010 A1
20100160854 Gauthier Jun 2010 A1
20100168535 Robinson et al. Jul 2010 A1
20100177375 Seyfried Jul 2010 A1
20100185142 Kamen et al. Jul 2010 A1
20100185182 Alme et al. Jul 2010 A1
20100198034 Thomas et al. Aug 2010 A1
20100198182 Lanigan et al. Aug 2010 A1
20100198183 Lanigan et al. Aug 2010 A1
20100211002 Davis Aug 2010 A1
20100212407 Stringham et al. Aug 2010 A1
20100212675 Walling et al. Aug 2010 A1
20100214110 Wang et al. Aug 2010 A1
20100217154 Deshmukh et al. Aug 2010 A1
20100217621 Schoenberg Aug 2010 A1
20100271218 Hoag et al. Oct 2010 A1
20100271479 Heydlauf Oct 2010 A1
20100273738 Valcke et al. Oct 2010 A1
20100292634 Kircher Nov 2010 A1
20100295686 Sloan et al. Nov 2010 A1
20100298765 Budiman et al. Nov 2010 A1
20100317093 Turewicz et al. Dec 2010 A1
20100318025 John Dec 2010 A1
20110000560 Miller et al. Jan 2011 A1
20110001605 Kiani et al. Jan 2011 A1
20110004186 Butterfield Jan 2011 A1
20110009797 Kelly et al. Jan 2011 A1
20110028885 Eggers et al. Feb 2011 A1
20110040247 Mandro et al. Feb 2011 A1
20110046558 Gravesen et al. Feb 2011 A1
20110062703 Lopez et al. Mar 2011 A1
20110064612 Franzoni et al. Mar 2011 A1
20110071464 Palerm Mar 2011 A1
20110071844 Cannon et al. Mar 2011 A1
20110072379 Gannon Mar 2011 A1
20110077480 Bloom et al. Mar 2011 A1
20110078608 Gannon et al. Mar 2011 A1
20110099313 Bolanowski Apr 2011 A1
20110105983 Kelly et al. May 2011 A1
20110106561 Eaton, Jr. et al. May 2011 A1
20110137241 DelCastilio et al. Jun 2011 A1
20110144595 Cheng Jun 2011 A1
20110160649 Pan Jun 2011 A1
20110162647 Huby et al. Jul 2011 A1
20110172918 Tome Jul 2011 A1
20110175728 Baker, Jr. Jul 2011 A1
20110190598 Shusterman Aug 2011 A1
20110190694 Lanier et al. Aug 2011 A1
20110264006 Ali et al. Oct 2011 A1
20110264043 Kotnick et al. Oct 2011 A1
20110282321 Steil et al. Nov 2011 A1
20110320049 Chossat et al. Dec 2011 A1
20120025995 Moberg et al. Feb 2012 A1
20120059234 Barrett et al. Mar 2012 A1
20120068001 Pushkarsky et al. Mar 2012 A1
20120095433 Hungerford et al. Apr 2012 A1
20120123322 Scarpaci et al. May 2012 A1
20120143116 Ware et al. Jun 2012 A1
20120180790 Montgomery Jul 2012 A1
20120185267 Kamen et al. Jul 2012 A1
20120191059 Cummings et al. Jul 2012 A1
20120194341 Peichel et al. Aug 2012 A1
20120203177 Lanier Aug 2012 A1
20120226350 Rudser et al. Sep 2012 A1
20120245525 Pope et al. Sep 2012 A1
20120259278 Hayes et al. Oct 2012 A1
20130006666 Schneider Jan 2013 A1
20130009551 Knapp Jan 2013 A1
20130012880 Blomquist Jan 2013 A1
20130012917 Miller et al. Jan 2013 A1
20130041342 Bernini et al. Feb 2013 A1
20130083191 Lowery et al. Apr 2013 A1
20130085443 Lowery et al. Apr 2013 A1
20130085689 Sur et al. Apr 2013 A1
20130110538 Butterfield et al. May 2013 A1
20130150766 Olde et al. Jun 2013 A1
20130150821 Bollish et al. Jun 2013 A1
20130158504 Ruchti et al. Jun 2013 A1
20130197930 Garibaldi et al. Aug 2013 A1
20130201482 Munro Aug 2013 A1
20130116649 Kouyoumjian et al. Sep 2013 A1
20130253430 Kouyoumjian et al. Sep 2013 A1
20130261993 Ruchti et al. Oct 2013 A1
20130274576 Amirouche et al. Oct 2013 A1
20130281965 Kamen et al. Oct 2013 A1
20130291116 Homer Oct 2013 A1
20130296823 Melker et al. Nov 2013 A1
20130296984 Burnett et al. Nov 2013 A1
20130318158 Teng et al. Nov 2013 A1
20130345658 Browne et al. Dec 2013 A1
20130345666 Panduro et al. Dec 2013 A1
20140039446 Day Feb 2014 A1
20140224829 Capone et al. Aug 2014 A1
20140267563 Baca et al. Sep 2014 A1
20140350513 Oruklu et al. Nov 2014 A1
20140358077 Oruklu et al. Dec 2014 A1
20150025453 Ledford et al. Jan 2015 A1
20150033073 Yang et al. Jan 2015 A1
20150168958 Downie et al. Jun 2015 A1
20150224252 Borges et al. Aug 2015 A1
20150246175 Shubinsky et al. Sep 2015 A1
20150343141 Lindo et al. Dec 2015 A1
20160042264 Borges et al. Feb 2016 A1
20160103960 Hume et al. Apr 2016 A1
20160110088 Vik et al. Apr 2016 A1
20160151560 Toro et al. Jun 2016 A1
20160151562 Magers et al. Jun 2016 A1
20160175517 Sileika et al. Jun 2016 A1
20160193604 McFarland et al. Jul 2016 A1
20160256622 Day et al. Sep 2016 A1
20160339167 Ledford et al. Nov 2016 A1
20170043089 Handler Feb 2017 A1
20180018440 Sugawara Jan 2018 A1
20180028749 Dumas, III et al. Feb 2018 A1
20190091401 Ruchti et al. Mar 2019 A1
20190101425 Ruchti et al. Apr 2019 A1
20190117890 Oruklu et al. Apr 2019 A1
20190196770 Fryman Jun 2019 A1
20190262535 Shubinsky et al. Aug 2019 A1
20190282757 Gylland et al. Sep 2019 A1
Foreign Referenced Citations (171)
Number Date Country
2013216679 Sep 2013 AU
P10704229-9 Nov 2009 BR
31 12 762 Jan 1983 DE
34 35 647 Jul 1985 DE
35 30 747 Mar 1987 DE
37 20 664 Jan 1989 DE
38 27 444 Feb 1990 DE
197 34 002 Sep 1998 DE
199 01 078 Feb 2000 DE
198 40 965 Mar 2000 DE
198 44 252 Mar 2000 DE
199 32 147 Jan 2001 DE
102 49 238 May 2004 DE
103 52 456 Jul 2005 DE
0 282 323 Sep 1988 EP
0 291 727 Nov 1988 EP
0 319 272 Jun 1989 EP
0 319 275 Jun 1989 EP
0 335 385 Oct 1989 EP
0 337 092 Oct 1989 EP
0 341 582 Nov 1989 EP
0 370 162 May 1990 EP
0 387 724 Sep 1990 EP
0 429 866 Jun 1991 EP
0 441 323 Aug 1991 EP
0 453 211 Oct 1991 EP
0 462 405 Dec 1991 EP
0 501 234 Sep 1992 EP
0 516 130 Dec 1992 EP
0 519 765 Dec 1992 EP
0 643 301 Mar 1995 EP
0 683 465 Nov 1995 EP
0 431 310 Jan 1996 EP
0 589 439 Aug 1998 EP
0 880 936 Dec 1998 EP
0 954 090 Nov 1999 EP
0 960 627 Dec 1999 EP
1 174 817 Jan 2002 EP
1 177 802 Feb 2002 EP
1 197 178 Apr 2002 EP
1 500 025 Apr 2003 EP
1 813 188 Aug 2007 EP
2 062 527 May 2009 EP
2 228 004 Sep 2010 EP
2 243 506 Oct 2010 EP
2 381 260 Oct 2011 EP
254513 Oct 1981 ES
2 717 919 Sep 1995 FR
2 121 971 Jan 1984 GB
2 303 706 Feb 1997 GB
2 312 022 Oct 1997 GB
2 312 046 Oct 1997 GB
01-301118 Dec 1989 JP
01-308568 Dec 1989 JP
04-231966 Aug 1992 JP
07-502678 Mar 1995 JP
07-289638 Nov 1995 JP
11-128344 May 1999 JP
2000-111374 Apr 2000 JP
2000-510575 Aug 2000 JP
2000-515716 Nov 2000 JP
2001-356034 Dec 2001 JP
2002-506514 Feb 2002 JP
2002-131105 May 2002 JP
2003-038642 Feb 2003 JP
2003-050144 Feb 2003 JP
2005021463 Jan 2005 JP
2005-524081 Mar 2005 JP
2006-517423 Jul 2006 JP
2007-071695 Mar 2007 JP
2007-520270 Jul 2007 JP
2008-249400 Oct 2008 JP
4322661 Jun 2009 JP
2010-063767 Mar 2010 JP
WO 84000690 Mar 1984 WO
WO 84000894 Mar 1984 WO
WO 90007942 Jul 1990 WO
WO 91000113 Jan 1991 WO
WO 91016087 Oct 1991 WO
WO 91016416 Oct 1991 WO
WO 93004284 Mar 1993 WO
WO 95016200 Jun 1995 WO
WO 95031233 Nov 1995 WO
WO 96008755 Mar 1996 WO
WO 96025186 Aug 1996 WO
WO 96028209 Sep 1996 WO
WO 96041156 Dec 1996 WO
WO 97010013 Mar 1997 WO
WO 97030333 Aug 1997 WO
WO 98004304 Feb 1998 WO
WO 98012670 Mar 1998 WO
WO 98014234 Apr 1998 WO
WO 98019263 May 1998 WO
WO 98044320 Oct 1998 WO
WO 98056441 Dec 1998 WO
WO 99015216 Apr 1999 WO
WO 99051003 Oct 1999 WO
WO 99052575 Oct 1999 WO
WO 00013580 Mar 2000 WO
WO 00013726 Mar 2000 WO
WO 00041621 Jul 2000 WO
WO 01014974 Mar 2001 WO
WO 01033484 May 2001 WO
WO 01033710 May 2001 WO
WO 02005702 Jan 2002 WO
WO 02009795 Feb 2002 WO
WO 02027276 Apr 2002 WO
WO 02066101 Aug 2002 WO
WO 02087664 Nov 2002 WO
WO 03006091 Jan 2003 WO
WO 03053498 Jul 2003 WO
WO 03093780 Nov 2003 WO
WO 2004035115 Apr 2004 WO
WO 2004060455 Jul 2004 WO
WO 2004070556 Aug 2004 WO
WO 2004112579 Dec 2004 WO
WO 2005018716 Mar 2005 WO
WO 2005030489 Apr 2005 WO
WO 2005036447 Apr 2005 WO
WO 2005050526 Jun 2005 WO
WO 2005057175 Jun 2005 WO
WO 2005065146 Jul 2005 WO
WO 2005065749 Jul 2005 WO
WO 2005082450 Sep 2005 WO
WO 2005118015 Dec 2005 WO
WO 2006016122 Feb 2006 WO
WO 2006022906 Mar 2006 WO
WO 2007000426 Jan 2007 WO
WO 2007033025 Mar 2007 WO
WO 2007035567 Mar 2007 WO
WO 2007087443 Aug 2007 WO
WO 2008004560 Jan 2008 WO
WO 2008019016 Feb 2008 WO
WO 2008053193 May 2008 WO
WO 2008059492 May 2008 WO
WO 2008063429 May 2008 WO
WO 2008067245 Jun 2008 WO
WO 2008088490 Jul 2008 WO
WO 2008134146 Nov 2008 WO
WO 2009016504 Feb 2009 WO
WO 2009023406 Feb 2009 WO
WO 2009023407 Feb 2009 WO
WO 2009023634 Feb 2009 WO
WO 2009026420 Feb 2009 WO
WO 2009039203 Mar 2009 WO
WO 2009039214 Mar 2009 WO
WO 2009049252 Apr 2009 WO
WO 2009127683 Oct 2009 WO
WO 2010017279 Feb 2010 WO
WO 2010075371 Jul 2010 WO
WO 2010099313 Sep 2010 WO
WO 2010114929 Oct 2010 WO
WO 2010119409 Oct 2010 WO
WO 2010124127 Oct 2010 WO
WO 2010135646 Nov 2010 WO
WO 2010135654 Nov 2010 WO
WO 2010135670 Nov 2010 WO
WO 2010135686 Nov 2010 WO
WO 2010148205 Dec 2010 WO
WO 2011017778 Feb 2011 WO
WO 2011080188 Jul 2011 WO
WO 2011109774 Sep 2011 WO
WO 2012042763 Apr 2012 WO
WO 2012082599 Jun 2012 WO
WO 2012167090 Dec 2012 WO
WO 2013028524 Feb 2013 WO
WO 2013096769 Jun 2013 WO
WO 2015134478 Sep 2015 WO
WO 2017051271 Mar 2017 WO
WO 2017197024 Nov 2017 WO
WO 2017214441 Dec 2017 WO
Non-Patent Literature Citations (57)
Entry
Alaedeen et al., “Total Parenteral Nutrition-Associated Hyperglycemia Correlates with Prolonged Mechanical Ventilation and Hospital Stay in Septic Infants”, Journal of Pediatric Surgery, Jan. 2006, vol. 41, No. 1, pp. 239-244.
Aragon, Daleen Rn, Ph.D., CCRN “Evaluation of Nursing Work Effort and Perceptions About Blood Glucose Testing in Tight Glycemic Control”, American Journal of Critical Care, Jul. 2006, vol. 15, No. 4, pp. 370-377.
Baxter, “Baxter Receives 510(k) Clearance for Next-Generation SIGMA Spectrum Infusion Pump with Master Drug Library” Press Release, May 8, 2014, pp. 2. http://web.archive.org/web/ 20160403140025/http://www.baxter.com/news-media/newsroom/press-releases/2014/05_08 _14_sigma.pago.
Bequette, Ph.D., “A Critical Assessment of Algorithms and Challenges in the Development of a Closed-Loop Artificial Pancreas”, Diabetes Technology & Therapeutics, Feb. 28, 2005, vol. 7, No. 1, pp. 28-47.
Bequette, B. Wayne, Ph.D., “Analysis of Algorithms for Intensive Care Unit Blood Glucose Control”, Journal of Diabetes Science and Technology, Nov. 2007, vol. 1, No. 6, pp. 813-824.
Binder et al., “Insulin Infusion with Parenteral Nutrition in Extremely Low Birth Weight Infants with Hyperglycemia”, Journal of Pediatrics, Feb. 1989, vol. 114, No. 2, pp. 273-280.
Bode et al., “Intravenous Insulin Infusion Therapy: Indications, Methods, and Transition to Subcutaneous Insulin Therapy”, Endocrine Practice, Mar./Apr. 2004, vol. 10, Supplement 2, pp. 71-80.
Cannon, MD et al., “Automated Heparin-Delivery System to Control Activated Partial Thromboplastin Time”, Circulation, Feb. 16, 1999, vol. 99, pp. 751-756.
“CareAware® Infusion Management”, Cerner Store, as printed May 12, 2011, pp. 3, https://store.cerner.corn/items/7.
Chen et al., “Enabling Location-Based Services on Wireless LANs”, The 11th IEEE International Conference on Networks, ICON 2003, Sep. 28-Oct. 1, 2003, pp. 567-572.
Cheung et al., “Hyperglycemia is Associated with Adverse Outcomes in Patients Receiving Total Parenteral Nutrition”, Diabetes Care, Oct. 2005, vol. 28, No. 10, pp. 2367-2371.
Davidson et al., “A Computer-Directed Intravenous Insulin System Shown to be Safe, Simple, and Effective in 120,618 h of Operation”, Diabetes Care, Oct. 2005, vol. 28, No. 10, pp. 2418-2423.
Diabetes Close Up, Close Concerns AACE Inpatient Management Conference Report, Consensus Development Conference on Inpatient Diabetes and Metabolic Control, Washington, D.C., Dec. 14-16, 2003, pp. 1-32.
Fogt et al., Development and Evaluation of a Glucose Analyzer for a Glucose-Controlled Insulin Infusion System (Biostator®, Clinical Chemistry, 1978, vol. 24, No. 8, pp. 1366-1372.
Goldberg et al., “Clinical Results of an Updated Insulin Infusion Protocol in Critically III Patients”, Diabetes Spectrum, 2005, vol. 18, No. 3, pp. 188-191.
Halpern et al., “Changes in Critical Care Beds and Occupancy in the United States 1985-2000: Differences Attibutable to Hospital Size”, Critical Care Medical, Aug. 2006, vol. 34, No. 8, pp. 2105-2112.
Hospira, “Plum A+™ Infusion System” as archived Dec. 1, 2012, pp. 2. www.hospira.com/products_and_services/infusion_pumps/plum/index.
International Search Report and Written Opinion received in PCT Application No. PCT/US2008/087484 (ICUH.033WO), dated May 4, 2009 in 8 pages.
Lamsdale et al., “A Usability Evaluation of an Infusion Pump by Nurses Using a Patient Simulator”, Proceedings of the Human Factors and Ergonomics Society 49th Annual Meeting, Sep. 2005, pp. 1024-1028.
Magaji et al., “Inpatient Management of Hyperglycemia and Diabetes”, Clinical Diabetes, 2011, vol. 29, No. 1, pp. 3-9.
Mauseth et al., “Proposed Clinical Application for Tuning Fuzzy Logic Controller of Artificial Pancreas Utilizing a Personalization Factor”, Journal of Diabetes Science and Technology, Jul. 2010, vol. 4, No. 4, pp. 913-922.
Maynard et al., “Subcutaneous Insulin Order Sets and Protocols: Effective Design and Implementation Strategies”, Journal of Hospital Medicine, Sep./Oct. 2008, vol. 3, Issue 5, Supplement 5, pp. S29-S41.
Moghissi, Etie, MD, FACP, FACE, “Hyperglycemia in Hospitalized Patients”, A Supplement to ACP Hospitalist, Jun. 15, 2008, pp. 32.
Nuckols et al., “Programmable Infusion Pumps in ICUs: An Analysis of Corresponding Adverse Drug Events”, Journal of General Internal Medicine, 2007, vol. 23, Supp. 1, pp. 41-45.
Pretty et al., “Hypoglycemia Detection in Critical Care Using Continuous Glucose Monitors: An in Silico Proof of Concept Analysis”, Journal of Diabetes Science and Technology, Jan. 2010, vol. 4, No. 1, pp. 15-24.
Saager et al., “Computer-Guided Versus Standard Protocol for Insulin Administration in Diabetic Patients Undergoing Cardiac Surgery”, Annual Meeting of the American Society of Critical Care Anesthesiologists, Oct. 13, 2006.
Sebald et al., “Numerical Analysis of a Comprehensive in Silico Subcutaneous Insulin Absorption Compartmental Model”, 31st Annual International Conference of the IEEE Engineering in Medicine and Biology Society, Sep. 2-6, 2009, pp. 3901-3904.
Simonsen, Michael Ph.D., POC Testing, New Monitoring Strategies on Fast Growth Paths in European Healthcare Arenas, Biomedical Business & Technology, Jan. 2007, vol. 30, No. 1, pp. 1-36.
Smith, Joe, “Infusion Pump Informatics”, CatalyzeCare: Transforming Healthcare, as printed May 12, 2011, pp. 2.
Tang et al., “Linear Dimensionality Reduction Using Relevance Weighted LDA”, Pattern Recognition, 2005, vol. 38, pp. 485-493 http://staff.ustc.edu.cn/˜ketang/papers/TangSuganYacQin_PR04.pdf.
Thomas et al., “Implementation of a Tight Glycaemic Control Protocol Using a Web-Based Insulin Dose Calculator”, Anaesthesia, 2005, vol. 60, pp. 1093-1100.
Van Den Berghe, M.D., Ph.D., et al., “Intensive Insulin Therapy in Critically Ill Patients”, The New England Journal of Medicine, Nov. 8, 2001, vol. 345, No. 19, pp. 1359-1367.
Van Den Berghe, M.D., Ph.D., et al., “Intensive Insulin Therapy in the Medical ICU”, The New England Journal of Medicine, Feb. 2, 2006, vol. 354, No. 5, pp. 449-461.
Westbrook et al., “Errors in the Administration of Intravenous Medications in Hospital and the Role of Correct Procedures and Nurse Experience”, BMJ Quality & Safety, 2011, vol. 20, pp. 1027-1034.
Zakariah et al., “Combination of Biphasic Transmittance Waveform with Blood Procalcitonin Levels for Diagnosis of Sepsis in Acutely Ill Patients”, Critical Care Medicine, 2008, vol. 36, No. 5, pp. 1507-1512.
Alaris® Medical Systems, “Signature Edition® Gold—Single & Dual Channel Infusion System”, San Diego, CA, USA, date unknown, but believed to be at least as early as Nov. 29, 2008, pp. 70-74, 2-88 & 2-91.
Allegro, “3955 —Full-Bridge PWM Microstepping Motor Drive”, Datasheet, 1997, pp. 16.
Buhrdorf et al., “Capacitive Micromachined Ultrasonic Transducers and their Application”, Proceedings of the IEEE Ultrasonics Symposium, Feb. 2001, vol. 2, pp. 933-940.
Coley et al., “Performance of Three Portable Infusion-Pump Devices Set to Deliver 2 mL/hr”, American Journal of Health-System Pharmacy, Jun. 1, 1997, vol. 54, No. 11, pp. 1277-1280.
“Continually vs Continuously”, https://web.archive.org/web/20090813092423/http://www.diffen.com/difference/Continually_vs_Continuously, as accessed Aug. 13, 2009 in 4 pages.
“CritiCore® Monitor: Critical Fluid Output and Core Bladder Temperature Monitor”, BARD Urological Catheter Systems, Advertisement, 2005, pp. 2.
“Differential Pressure Transmitter, Series PD-39 X”, SensorsOne Ltd., Advertisement, Dec. 2005, pp. 2.
Dunster et al., “Flow Continuity of Infusion Systems at Low Flow Rates”, Anaesthesia and Intensive Care, Oct. 1995, vol. 23, No. 5, pp. 5.
“Froth”, http://www.merriam-webster.com/dictionary/froth, as accessed May 13, 2015 in 1 page.
Hospira, “Plum XL™ Series Infusion System” Technical Service Manual, Feb. 2005, Lake Forest, Illinois, USA, pp. i-vii, 5-14, 8-3.
Ilfeld et al., “Delivery Rate Accuracy of Portable, Bolus-Capable Infusion Pumps Used for Patient-Controlled Continuous Regional Analgesia”, Regional Anesthesia and Pain Medicine, Jan.-Feb. 2003, vol. 28, No. 1, pp. 17-23.
Ilfeld et al., “Portable Infusion Pumps Used for Continuous Regional Analgesia: Delivery Rate Accuracy and Consistency”, Regional Anesthesia and Pain Medicine, Sep.-Oct. 2003, vol. 28, No. 5, pp. 424-432.
JMS Co., Ltd., “Infusion Pump: OT-701”, Tokyo, Japan, 2002, pp. 4.
Kutcher et al., “The Effect of Lighting Conditions on Caries Interpretation with a Laptop Computer in a Clinical Setting”, Elsevier, Oct. 2006, vol. 102, No. 4, pp. 537-543.
Logan et al., “Fabricating Capacitive Micromachined Ultrasonic Transducers with a Novel Silicon-Nitride-Based Wafer Bonding Process”, IEEE Transactions on Ultrasonics, Ferroelectrics, and Frequency Control, May 2009, vol. 56, No. 5, pp. 1074-1084.
Merry et al., “A New, Safety-Oriented, Integrated Drug Administration and Automated Anesthesia Record System”, Anesthesia & Analgesia, Aug. 2001, vol. 93, No. 2 pp. 385-390.
Microchip Technology Inc., “MTA11200B; TrueGauge™ Intelligent Battery Management I.C.”, https://www.elektronik.ropia.eu/pdf/stock/mcp/mta11200b.pdf, 1995, pp. 44.
SGS-Thomson Microelectronics, “L6219—Stepper Motor Drive”, Datasheet, Dec. 1996, pp. 10.
SGS-Thomson Microelectronics, “PBL3717A—Stepper Motor Drive”, Datasheet, Apr. 1993, pp. 11.
Kim, M.D., et al., “Hyperglycemia Control of the Nil Per Os Patient in the Intensive Care Unit: Introduction of a Simple Subcutaneous Insulin Algorithm”, Nov. 2012, Journal of Diabetes Science and Technology, vol., 6, No. 6, pp. 1413-1419.
“Decision of the Administrative Council of Oct. 16, 2013 Amending Rule 135 and 164 of the Implementing Regulations to the European Patent Convention (CA/D 17/13)”, Official Journal EPO Nov. 2013, Nov. 2013, pp. 503-506. http://archive.epo.org/epo/pubs/oj013/11_13/11_5033.pdf.
“Decision of the Administrative Council of Oct. 27, 2009 Amending the Implementing Regulations to the European Patent Convention (CA/D 20/09)”, Official Journal EPO Dec. 2009, Dec. 2009, pp. 582-584. http://archive.epo.org/epo/pubs/oj009/12_09/12_5829.pdf.
Related Publications (1)
Number Date Country
20090177992 A1 Jul 2009 US
Provisional Applications (1)
Number Date Country
61014677 Dec 2007 US